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ABSTRACT 
THE IDENTIFICATION OF NOVEL REGULATORY ELEMENTS IN THE 
PROMOTERS OF HEAT SHOCK RESPONSE GENES 
S. Ncube 
M.Sc. thesis, Department of Biotechnology, Faculty of Science, University of the 
Western Cape, South Africa. 
Mammalian cells have evolved self-protective mechanisms that are activated in 
response to cellular stress, including non-lethal heat shock (heat shock response- 
HSR). These adaptive and cytoprotective mechanisms are mediated by heat shock 
factors that bind to cognate sequences in the promoters of heat shock responsive 
genes. The main objective of this study was to investigate promoter sequences of 
putative HSR genes for the presence of unique regulatory elements and modules 
that might be involved in the regulation of HSR. In order to achieve this objective, 
an in silico promoter analysis strategy was devised, which focused on the 
identification of promoter sequences and regulatory elements, and modelling of 
promoter modules by using Genomatix software tools such as MatInspector and 
ModelInspector. Results showed that two modules (EGRF_SP1F_01 and 
SP1F_CEBP_01) were conserved in the promoter sequences of three well-known 
Hsp-genes (Hsp90, Hsp105β and αβ-crystallin). Screening the 60 target gene 
promoters for the presence of the two modules revealed that 12 genes (20 %) 
contained both modules. These included Moesin, Proline-4 hydroxylase, Poly(A) 
binding protein and Formin-binding protein. None of these genes had been 
previously associated with heat shock response. 
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As a result, the expression of the 12 putative HSR genes in response to heat shock 
was further investigated using experimental analyses. This included optimisation 
of a heat shock system using cultured H9c2 cells, toxicity testing, Western blot 
analysis and qRT-PCR. Results obtained showed that pre-conditioned H9c2 cell 
cultures were significantly protected (p < 0.05) from pro-apoptotic effects of 
ethanol compared to control cells. Real-time quantitative reverse transcription 
polymerase chain reaction revealed that Atic, Pabpc1 and Cacybp were slightly 
up-regulated in cultured H9c2 cells after heat shock treatment. Known functions of 
these genes include mRNA processing, Ca
2+
 metabolism and regulation of the 
cytoskeleton. Thus the conclusion drawn from this study was that EGRF_SP1F_01 
and SP1F_CEBP_01 are unique modules that might be involved in the regulation 
of heat shock response in H9c2 cells. 
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CHAPTER 1.0: LITERATURE REVIEW 
1.1 Introduction  
Myocardial infarction, a clinical manifestation of ischemic heart injury, is one of 
the leading causes of death in modern society (World Health Organisation, 2010). 
Myocardial ischaemic injury is usually caused by severe impairment of the 
coronary blood supply, mostly as a result of occlusion of blood vessels by 
coronary atherosclerotic plaque or clamping during a surgical procedure, which 
cuts off the supply of oxygen and nutrients to the heart tissue (Hamacher-Brandy 
et al., 2006). The resulting condition of low oxygen and nutrient supply is called 
ischaemia and is associated with decreased intracellular ATP and low pH due to 
accumulation of lactate and retention of carbon dioxide (Gill et al., 2000). If the 
supply of oxygen and nutrients to the heart muscle is not rapidly restored, massive 
postischaemic cell death and tissue destruction may occur in the affected area 
(Figure 1.1).  
In order to restore blood flow and prevent irreversible damage to the myocardium, 
reperfusion of blood must be done following ischaemia. Unfortunately, 
reperfusion has also been shown to cause various injuries to the heart tissue, 
including membrane permeation, contractile abnormalities, calcium influx, and 
depletion of high-energy phosphates, which ultimately leads to cell death 
(Umansky and Tomei, 1997; Gottlieb et al., 1994). The damage inflicted to the 
myocardium as a result of the combined effects of ischaemia and reperfusion is 
referred to as ischaemic/reperfusion (I/R) injury. Additionally, increased 
production of reactive oxygen species (ROS) has been reported in cardiomyocytes 
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following I/R injury (Fleury et al., 2002; Cook et al., 1999; Von Harsdorf et al., 
1999; Zweier et al., 1987). Excessive intracellular generation of ROS causes 
peroxidation of membrane lipids, damage proteins and inactivate enzymes (Yellon 
and Hausenloy, 2007; Butterfield et al., 1997), which eventually results in cell 
death.  
 
Figure 1.1: Images of a whole heart and coronary arteries showing damage (dead 
heart muscle) caused by blockage of the coronary artery. 
A. Damaged heart muscle as a result of blockage of the coronary arteries that 
supply oxygen and nutrients to the heart muscle. 
B. A cross section of the coronary artery showing a build-up of plaque and a blood 
clot that block blood flow resulting in death of heart muscle cells in the affected 
area (adapted from http://www.speakingofresearch.files.wordpress.com/). 
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In spite of the controversy surrounding the role of apoptosis in myocardial 
infarction, cumulative evidence suggests that indeed apoptosis contributes to loss 
of cardiomyocytes following I/R injury (Freude et al., 2000; Schunkert and 
Riegger, 2000; Zhao et al., 2000; Gottlieb and Engler, 1999; James, 1998; 
Kajtsura et al., 1996). Mitochondrial stress, ER stress, oxidative stress, calcium 
overload, and other stimulators of pro-apoptotic factors are believed to be the 
pathophysiological triggers of apoptosis in the myocardium (Opie, 1993). 
Cardiomyocytes are terminally differentiated cells and once dead are rarely 
replaced (Kimes and Brandt, 1976). Thus loss of cardiomyocytes as a result of I/R 
injury contributes to reduced function of the heart muscle, which eventually 
manifests as myocardial infarction.  
Cellular effects of hyperthermia are similar to those caused by 
ischaemia/reperfusion. These include inhibition of cap-dependent (i.e., general) 
protein synthesis, disintegration of the cytoskeleton, disruption of numerous 
metabolic processes, mitochondrial damage and uncoupling of oxidative 
phosphorylation (Cuesta et al. 2000; Liu et al., 1992). These often lead to cell 
death when the stress is persistent and/or excessive. However, exposure of living 
cells, including cardiomyocytes, to a mild, non-lethal thermal stress (5 
o
C above 
normal growth temperature) has been shown to activate adaptive and protective 
cellular mechanisms that are collectively known as the stress response (SR). The 
SR increases the ability of a cell to cope with stress and to withstand fatal 
subsequent stress events (Quigney et al., 2003).  This phenomenon is referred to as 
heat shock preconditioning. Although originally discovered as a response to 
thermal stress (Ritossa, 1962), the SR is triggered by a variety of stressful 
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conditions that interfere with protein folding, transport and function (Kaufman, 
2002).  
In addition to heat shock preconditioning, studies have demonstrated that 
subjecting the heart muscle to brief episodes of mild ischaemia (ischaemic 
preconditioning-IP) also preserve the myocardium against fatal I/R injury (Arnaud 
et al., 2003; Brar et al., 1999; Piot et al., 1999; Martin et al., 1997). This discovery 
has led to intense investigation into the subject, more so over the past decade. The 
aim is to develop a better understanding of the mediators and mechanisms 
underlying cytoprotection, which comes about as a result of preconditioning, in the 
hope that these may provide novel targets for therapeutic intervention against 
chronic and acute I/R injury. To date the cytoprotective effects of heat shock- and 
ischemic preconditioning have largely been ascribed to increased expression of 
Hsps. However, the mechanism(s) of this preservation is still not fully understood. 
Thus it is conceivable that there are yet-to-be-discovered mediators in these 
cytoprotective pathways.  
This literature review summarises present knowledge about the effects of stress on 
cellular functions, the role of stress-mediated apoptotic signalling pathways in 
cardiomyocyte death, cellular response to stress, the cytoprotective roles of stress 
proteins, the importance of stress proteins as potential therapeutic targets against 
fatal I/R injury, and recent developments in in silico analysis of gene regulation. 
The last section of this chapter outlines the history behind this study and the 
objectives that were set. 
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1.2 The effects of stress on cellular function 
Throughout their lifespan, cells and tissues are constantly exposed to a plethora of 
harsh environmental (heat shock, UV irradiation, toxic chemicals), physiologic 
(oxygen radicals, pH fluctuations), and pathophysiological (inflammation, tissue 
injury, infection, proteasome inhibitors, I/R injury) stress conditions. Exposure to 
such stressful conditions causes severe damage to cellular proteins and promotes 
intracellular aggregation of damaged/misfolded proteins. These protein aggregates 
disrupt cellular homeostasis and induce cellular stress, which might activate 
apoptotic signalling pathways, leading to the death of the stressed cell (Tannous et 
al., 2008; Demasi and Davies, 2003; Bucciantini et al., 2002; Bence et al., 2001; 
Wttenbach et al., 2000).  
Typically, cells respond to these potentially deleterious perturbations by inducing 
the expression of a set of evolutionary conserved genes that encode a very large 
and diverse class of proteins that are collectively known as stress proteins. Heat 
shock proteins (Hsps) (section 1.5) are the most common and best-studied 
members of stress proteins. Figure 1.2 summarises apoptotic signalling pathways 
(pathways 2, 3, 4, 5, and 6) that are activated by various stress conditions leading 
to apoptosis. However, also shown is a defence pathway (pathway 1) which 
protects the cell against stress-induced death. The cytoprotective effects are 
brought about by induced expression of stress proteins, including Hsps which, in 
addition to their protein folding roles (section 1.9), have also been shown to block 
apoptotic signalling pathways at various points (section 1.10).  
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Figure 1.2: A schematic illustration of major cellular pathways that are activated 
in response to stress.  
Exposure of cells to environmental, physiologic, and pathophysiological stressors 
activates apoptosis signalling pathways (pathways 2 to 6) which leads to cell 
death. Pathway 1 is a protective pathway showing stress-induced activation of the 
heat shock transcription factor 1 (HSF1) which regulates transcription of Hsps. 
Hsps function as molecular chaperones that assist proteins to fold into native 
conformations (pathway A) and their synthesis exhibits autoregulation (pathway 
B). Several Hsps have been shown to block apoptotic signalling pathways at 
various points (pathways C to G). In some tumour cells, Hsps are also expressed at 
the cell surface where they may play a role as antigen-presenting cells (pathway 
H). Bold arrows represent the major initiation events; dotted lines represent 
inhibitory events; HSP, heat shock protein (adapted from Jolly and Morimoto, 
2000). 
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1.3 Apoptosis 
Apoptosis (Kerr et al., 1972) is a distinct, genetically-controlled, energy-
dependent form of cell death that occurs without inducing an inflammatory 
response in surrounding tissues. It plays a vital role in several physiological 
processes including embryonic development, maintenance of normal adult tissue 
homeostasis, and immune response (Fink and Cookson, 2005; Kroemer et al., 
1995). However, deregulation of apoptosis is implicated in the pathenogenesis of 
several neurodegenerative disorders (Sherman and Goldberg, 2001; Mattson et al., 
2000; Nishimoto et al., 1997), cancers (Webb et al., 1997), and cardiac 
dysfunction (Danial and Korsmeyer, 2004; Nicholson, 1999; Umansky and Tomei, 
1997).  
Apoptotic signalling is induced by a wide variety of stimuli and is mediated by 
cysteine-dependent aspartic acid-specific cysteine proteases (caspases) (Danial and 
Korsmeyer, 2004; Korsmeyer, 2004; Nicholson, 1999; Zheng et al., 1999; 
Thornberry and Lazebnik, 1998). Characteristic hallmarks of apoptosis include 
loss of plasma membrane symmetry (i.e., translocation of phophatidylserine- PS, 
from the inner to the outer leaflet of the plasma membrane), plasma membrane 
blebbing, cytoplasmic shrinkage, chromatin condensation, activation of caspases, 
DNA fragmentation, and the collapse of the apoptotic cell into small intact 
membrane-bound fragments (apoptotic bodies) (Fink and Cookson, 1995; Martin 
et al., 1995).  
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1.3.1 Mitochondrial stress-induced apoptotic signalling pathway 
A variety of cytotoxic agents, particularly those that cause increased generation of 
ROS, cause mitochondrial stress. This results in the permeabilisation of the outer 
mitochondrial membrane and consequent release of pro-apoptotic factors, 
including cytochrome c, apoptosis inducing factor (AIF), pro-capases, 
Smac/Diablo, HtrA2/Omi and endonuclease G, into the cytosol (Gill et al., 2006; 
Donovan and Gotter, 2004). In the cytosol, cytochrome c interacts with apoptosis 
protease activating factor-1 (Apaf-1), thereby triggering the ATP-dependant 
oligomerisation of Apaf-1 (Cecconi, 1999). Oligomerised Apaf-1 binds to pro-
caspase-9 leading to the formation of the caspase-9 activation complex (the 
apoptosome), which in turn triggers the proteolytic maturation of pro-caspase-3 
leading to apoptotic cell death (Figure 1.3).  
1.3.2 The endoplasmic reticulum (ER) stress-mediated apoptotic signalling 
pathway 
The role of prolonged ER stress in regulation of apoptosis is relatively new and 
not yet fully understood. ER stress-mediated cell death (Figure 1.4) has been 
shown to involve elements of both the death receptor- and the mitochondrial 
apoptotic signalling pathways (Boyce and Yuan, 2006). Studies suggest the 
involvement of caspase-4, -7 and -12 (Rao et al., 2001; Nakagawa et al., 2000).  
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Figure 1.3: A schematic illustration of the mitochondrial stress-induced apoptotic 
signalling pathway.  
Cellular stress (e.g., ROS) induces permeabilisation of the outer mitochondrial 
membrane, leading to the release of cytochrome c into the cytosol. Cytochrome c 
binds to Apaf-1 in the cytosol and triggers its oligomerisation. This complex binds 
and activates pro-caspase-9, in the presence of dATP, which leads to the 
downstream activation of capase-3 and apoptosis (adapted from Ogata and 
Takahashi, 2003). 
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Figure 1.4: ER stress-mediated apoptotic signalling pathways.  
Excessive or prolonged ER stress leads to the activation of PERK and, eventually, 
the GADD34/PP1 phosphatase complex, which dephosphorylates eIF2, promoting 
apoptosis. Caspase-12 (mice) or -4 (humans) bind to the outer ER membrane and 
are activated by IRE1 and TRAF2 or by cleavage by calpain, which is in turn 
activated by the release of calcium from ER. Bcl-2 family members also regulate 
apoptosis induced by ER stress, both through the regulation of calcium flux and 
amplification of the apoptotic signal through the mitochondrial pathway (adapted 
from Boyce and Yuan, 2006).  
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Thus the regulation of apoptosis determines the ability of a cell to survive 
potentially harmful cellular insults. Therefore regulatory elements that are 
involved in regulation of stress response and apoptosis directly influence cell 
longivity.  
1.4 Cellular defence mechanism against stress and cell death  
The ability of a cell to respond to a wide variety of physiological stresses is critical 
to its survival. The ER regulates several essential cellular functions including post-
translational modification, folding and assembly of newly synthesised proteins 
destined for secretion or routing into various subcellular compartments, Ca
2+ 
homeostasis, and cellular response to stress (Berridge, 1995; Rapoport, 1992; 
Sambrook, 1990). ER perturbations such as oxidative stress, inhibition of protein 
glycosylation, impairment of protein transport from the ER to the Golgi, depletion 
of intracellular Ca
2+
, ER lipid and glycolipid imbalances and an excessive 
accumulation of unfolded/misfolded proteins causes ER stress and cellular 
damage, which may result in apoptosis. Mild ER stress activates a self-protective 
cellular mechanism known as the ER stress response (ESR) which enables cells to 
adapt and survive under stressful conditions (Ron and Walter, 2007; Boyce and 
Yuan, 2006; Kaufman, 1999; Lee, 1992). The ESR function to restore normal ER 
homeostasis through activation of the unfolded protein response (UPR) and the 
proteasome-dependent ER-associated degradation (ERAD) (Figure 1.5). The UPR 
increases the polypeptide folding capacity of the ER by coordinated transcriptional 
activation of multiple UPR-target genes (e.g., Hsps, inositol-requiring enzyme 
[IRE1], PKR- like ER kinase, and activating transcriptional factor 6 [ATF6]), 
whilst ERAD rapidly removes irreversibly damaged proteins from the ER (Boyce 
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and Yuan, 2006; Schröder and Kaufman, 2005a; Schröder and Kaufman, 2005b; 
Yoshida et al., 2000). Table 1.1 shows some of the proteins that are targeted for 
degradation by ERAD. 
 
Figure 1.5: A schematic model illustrating the coordinated action of the ESR 
through the UPR and ERAD.  
Nascent, unfolded proteins enter the ER, where they are folded and are passed on 
to the secretory pathway. Irreversibly misfolded or damaged proteins are removed 
by ERAD. Cellular stress or dysfunction of ERAD results in intracellular 
accumulation of misfolded proteins leading to activation of the UPR. The UPR 
reduces levels of misfolded proteins by regulating transcription of genes that 
encode molecular chaperones, promoting transit to the secretory pathway, and 
enhancing the rate of ERAD (adapted from Travers et al., 2000).  
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Table 1.1: A list of abnormal proteins that are targeted for degradation by ERAD 
(adapted from Sherman and Goldberg, 2001). 
a) Incomplete proteins 
b) Misfolded proteins (from mutations and biosynthetic errors) 
c) Denatured proteins 
d) Free subunits of multimeric complexes 
e) Proteins that fail to bind cofactors 
f) Oxidant-damaged proteins 
g) Membrane or secretory proteins that fail to fold in the endoplasmic 
reticulum (ER) 
h) Misdirected proteins (in incorrect compartments) 
 
1.5 Stress or “Heat shock” proteins: Definitions and nomenclature 
The term “heat shock” proteins has been maintained as a legacy of Ritossa‟s 
ground-breaking discovery in 1962 who observed that exposure of larval salivary 
glands of Drosophila to elevated temperature result in appearance of new puffs in 
the giant chromosomes of these cells (Ritossa, 1962). These puffs represent 
transcriptional induction of Hsps in response to heat shock (Lindquist and Craig, 
1988; Tissieres et al., 1974). Although named “heat shock” proteins based on the 
original observation that they were induced in response to elevated temperature, 
the term is misleading since these proteins are induced by a wide variety of stress 
stimuli, including, oxidative stress, heavy metals, inhibitors of metabolism, fever, 
inflammation, and I/R injury (Benjamin and McMillan, 1998). Hence the term 
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“stress proteins” is preferred. However, both terms are used synonymously 
throughout this thesis.  
Stress proteins belong to very large and diverse multigene families that constitute 
an ancient and essential cellular defence mechanism against a wide range of 
potentially harmful conditions. Genes encoding stress proteins are amongst the 
most evolutionary conserved in many organisms ranging from prokaryotes such as 
E. coli to more complex multicellular mammals (Ferder and Hofmann, 1999; Fink, 
1999; Lindquist and Craig 1988; Lindquist, 1986). For example, among eukaryotic 
organisms the identity of the nucleotide sequence of the Hsp70-gene varies from 
60 to 78  (Kiang and Tsokos, 1998). Compared with the human hsp70-gene, the 
Drosophila Hsp70-gene and the E. coli dnaK-gene have a 72 and 50  identities, 
respectively (Hunt and Calderwood, 1990).  This strong evolutionary conservation 
of stress proteins and their ability to respond to a wide variety of stressful stimuli 
that is potentially damaging to the cell suggests that they are crucial for cell 
survival. Some of these stress proteins (e.g., Hsc70) are constitutively synthesised 
by cells under normal conditions for routine housekeeping purposes. Thus stress 
proteins are required even in unstressed cells and their functions become even 
more crucial under stressful conditions.  
Conventionally, Hsps are classified into families according to their related 
function and molecular weight in kilodaltons (kDa) (Hightower and Hendershot, 
1997; Lindquist and Craig 1988). Family names are conventionally written in 
capital letters, for example, the HSP70 family. Some proteins that were first 
discovered in a non-related domain carry particular names like the major structural 
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ocular lens protein -crystallin or those proteins targeting abnormal proteins for 
degradation, i.e., ubiquitins (Benjamin and McMillan, 1998). The name of some 
Hsps that are restricted to specific organelles is often preceded by an indication of 
their cellular localisation, for example, mitochondrial Hsp75 (mt-Hsp75). 
Additionally, a distinction has been made between members that are constitutively 
expressed (e.g., Hsc70 and Hsp90 ) and their inducible isoforms that are almost 
absent under normal conditions but are rapidly synthesised in response to cellular 
stress (Hsp70 and Hsp90  respectively). However, this distinction is arbitrary, 
since emerging evidence indicates that such relationships depend on cell- and 
tissue-specific expression (Snoeckx et al., 2001). The synthesis of some stress 
proteins increases in response to lowered extracellular glucose concentrations and 
these are called glucose-related proteins (Grps).  However, other stimuli, such as 
depletion of intracellular calcium stores or inhibition of protein glycosylation can 
also lead to an increase in Grp synthesis (Snoeckx et al., 2001). Grps are members 
of various HSP families and comprise Grp58, Grp78, Grp94, and Grp170 and they 
are all localised in the ER. The nomenclature and classification for related Hsps in 
prokaryotic and eukaryotic organisms differs. 
1.6 The role of stress proteins in diseases 
The expression of stress proteins has been shown to have both deleterious and 
beneficial effects in the cell. Deregulated expression of Hsps has been implicated 
in tumourigenesis where they presumably function as modifiers of protein activity, 
in particular, components of the cell cycle machinery, kinases, and several other 
proteins implicated in cancer progression. Increased levels of members of the 
HSP70 and HSP27 families have been detected in a number of cancers, including 
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breast cancer and endometrial cancer (Jolly and Morimoto, 2000), and this is 
consistent with the observations that Hsps interfere with apoptotic signalling 
pathways. On the other hand, prior induction of Hsps has been shown to have a 
protective effect against subsequent fatal thermal and I/R injury.    
1.7 Expression of stress proteins in the cardiovascular tissues 
Several stress proteins are expressed in the cardiovascular system either 
constitutively or in response to specific stressors (Snoeckx et al., 2001; Benjamin 
and McMillan, 1998). In mice, for example, Hsp27, Hsc70 and Hsp84 are 
constitutively expressed in the heart, but at lower levels compared with other 
tissues (Tanguay et al., 1993). In unstressed rats, the heart contains relatively high 
levels of -crystallin, whereas intermediate levels of Hsp27 have been reported 
(Beck et al., 1995). In both human and rat heart, Hsp27 has been detected in 
endothelial cells, smooth muscle cells, and cardiomyocytes, whereas -crystallin 
is reportedly present only in the cardiomyocytes where it is constitutively 
abundant (Klemenz et al., 1993; Salo et al., 1991). -crystallin plays an essential 
role in cardiac development where it activates genetic programs responsible for 
cardiac morphogenesis (Snoeckx et al., 2001). The induced expression of some of 
the Hsps in the heart in response to hyperthermia and I/R injury, and their 
protective roles against subsequent stress will be discussed in the following 
sections.  
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1.8 The protective effect of stress proteins in the myocardium 
It is well-established that preconditioned cells are less susceptible to cytotoxicity 
induced by various stimuli including hyperthermia, heavy metals, growth factor 
withdrawal, radiation and anti-cancer drugs (Jäättelä, 1999; Samali and Orrenius, 
1998; Samali and Cotter, 1996). The clinical implication of this cytoprotection has 
attracted a lot of attention, particularly of those in cardiac research. Numerous 
studies have been done using both cultured cardiomyocytes and intact hearts in 
models simulating I/R injury. Currie and co-workers (Currie, 1987; Currie et al., 
1988) were amongst the first researchers to demonstrate the cytoprotective effects 
of heat shock preconditioning by exposing rats to elevated temperatures and then 
removing their hearts and exposing them to ischemia on a Langendorff perfusion 
apparatus. They demonstrated that the hearts isolated from rats which had prior 
exposure to elevated temperature had improved recovery of contractile function 
following subsequent ischemia and reperfusion compared to hearts from control 
animals. Also they showed that the reperfusion damage was significantly reduced 
in the heat-shocked hearts. Their findings demonstrated, for the first time, that 
there was a positive correlation between stress-induced expression of Hsp 
expression in the intact heart and a protective effect against subsequent exposure 
to ischaemia/reperfusion. These observations raised the question of whether a 
similar protective effect would be observed in hearts exposed to myocardial 
ischaemia within the whole animal following a prior exposure to heat shock. This 
was confirmed by Donnelly et al. (1992) who reported a significant reduction of 
infarct size when rat hearts were exposed to 35 minutes of left coronary artery 
occlusion in the whole animal following exposure to heat shock. Researchers soon 
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realised that the induction of stress proteins was not only in response to thermal 
stress but to a wide variety of stressors. Marber et al. (1993) reported that brief 
episodes of cardiac ischaemia induced Hsp synthesis and also reduced infarct size 
when the hearts were subsequently exposed to ischaemia in the intact animal.  
Thus in vivo induction of stress proteins in the intact heart or in cardiac cells in 
culture produces a protective effect against subsequent damaging thermal or I/R 
injury (Arnaud et al., 2003; Brar et al., 1999; Martin et al., 1997). Some studies 
have gone further and demonstrated that the protective effect correlates with the 
amount of Hsps induced (Hutter et al., 1994; Marber, et al., 1994). The majority 
Hsps, including Hsp70 and Hsp27, have since been over-expressed in cardiac 
myocytes and other mammalian cell lines where they confer cytoprotective effects 
against thermal stress or simulated ischaemia. More recently Lusardi et al. (2010) 
showed that ischaemic pre-conditioning regulates microRNA expression in the 
mouse brain cortex, which in turn regulate post-transcriptional gene expression of 
target genes, most of which encode transcriptional regulators. They suggested that 
microRNAs and their target genes (e.g., methyl-CpG binding protein 2) could 
serve as effectors of ischemic preconditioning-induced tolerance. 
Different Hsps respond differently to various stimuli and have different 
cytoprotective effects. The combined expression of Hsp60 and Hsp10 in cardiac 
myocytes has been shown to protect mitochondrial function and to protect against 
apoptotic cell death induced by simulated ischaemia/reoxygenation (Lin et al., 
2001). However, role of Hsp60 as an antiapoptotic and cytoprotective protein is 
not as well established as that of Hsp70. Hsp70 over-expression has been shown to 
protect cells against both thermal and simulated ischaemic stress (Mosser et al., 
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2000). Martin et al. (1997) demonstrated that cardiac cells over-expressing Hsp27 
or -crystallin were protected from simulated ischaemia and that decreasing 
levels of endogenous Hsp27 enhanced the damaging effects of a subsequent 
ischaemic stimulus.  
These observations raised the speculation that stimulating over-expression of 
individual stress proteins or a combination of stress proteins in vivo may be of 
therapeutic importance. Consequently this has led to intensive research aimed at 
elucidating the mechanism(s) mediating these protective effects by identifying 
specific biological processes that are targeted by these protective proteins. These 
include apoptotic signalling pathways.  
1.9 Hsps function as molecular chaperones 
The majority of stress proteins function as molecular chaperones that facilitate the 
correct folding, assembly, and degradation of other proteins (Fink, 1999; Hendrick 
and Hartl, 1993). They include members of the HSP70, HSP90, HSP104, 
HSP40/DnaJ, and small HSP (e.g., Hsp27, -crystallins) families (Narberhaus, 
2001; Morimoto et al., 1994; Georgopoulos and Welch, 1993; Gething and 
Sambrook, 1992; Ellis and van der Vies, 1991). Molecular chaperones have 
critical roles in cardiac function (Snoeckx et al., 2001; Benjamin and McMillan, 
1998) and their functions include (i) transiently binding nascent polypeptide 
chains and delay their folding until translation is complete, (ii) maintaining 
polypeptide chains in an appropriate conformation suitable for translocation across 
organelle membranes, (iii) selectively binding to denatured or partially unfolded 
polypeptides, preventing intracellular protein aggregation, and (iv) assisting in 
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degrading toxic metabolites by promoting ubiquitination and proteasome lysis 
(Benjamin and McMillan, 1998).   
1.9.1 Cytosolic and nuclear chaperones 
The HSP70 family of stress proteins constitute the most conserved and best 
studied class of Hsps. Eukaryotic cells express several HSP70 family members 
including constitutively expressed Hsc70, stress-inducible Hsp70 (also referred to 
as Hsp70i or Hsp72) and Grp78 which is localised in the ER (Jäättelä, 1999; 
Tavaria et al., 1996). All members of the Hsp70 chaperone class possess two 
distinct domains: a highly conserved N-terminal ATPase domain and a more 
divergent C-terminal domain, which binds short hydrophobic peptides of target 
substrates (Benjamin and McMillan, 1998). Under normal, unstressed conditions 
Hsp70 bind to and stabilise nascent polypeptides in an ATP-dependent manner and 
maintain them in an unfolded or partially folded state until they reach their final 
cellular compartment. It also assists in the assembly of multiprotein complexes 
and the transport of proteins across cellular membranes (Parcellier et al., 2003; 
Fink, 1999). Figure 1.6 shows a model for the cellular chaperone function of 
Hsc70.  
Under stressful conditions, the induced synthesis of Hsp70 enhances the ability of 
cells to cope with increased concentrations of unfolded or denatured proteins 
(Marber et al., 1995). Specifically, Hsp70 has been shown to associate with 
cytoskeletal proteins, cell surface glycoproteins, calmodulin, and saturated long-
chain fatty acids, like palmitate, stearate, and myristate (Huang et al., 2009; 
Snoeckx et al., 2001; Sun et al., 2000).  
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Figure 1.6: Schematic illustration of interactions between the chaperones Hsc70 
and nascent peptide chains or unfolded proteins.  
Hsc70 recognise and bind to domains in unfolded proteins and nascent 
polypeptides as they exit ribosomes. Partially folded proteins that are shuttled into 
the ER and mitochondria are further bound and folded by ER-resident (e.g., 
Grp78) and mitochondria-resident (e.g., mt-Hsp75) chaperones. Grp78, glucose-
related protein 78; mt-Hsp75, mitochondrial 75-kDa heat shock protein (adapted 
from Snoeckx et al., 2001). 
 
HSP90 proteins are one of the most abundant cytosolic proteins, making up 1-2% 
of cytosolic proteins and can further accumulate in response to stress. Members of 
the Hsp90 family include the ATP-dependent chaperones Hsp90 , Hsp90 , and 
Grp94 (Pearl and Prondromou, 2006; Csermely et al., 1998). The main chaperone 
role of HSP90 proteins is promoting the conformational maturation of 
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transcription factors and signal transducing kinases including ligand-dependent 
transcription factors such as MyoD, tyrosin kinases such as v-Src, and 
serine/threonine kinases such as Raf-1 (Parcellier et al., 2003).  
Mammalian Hsp60, also called chaperonin, is a constitutively expressed protein 
found primarily within the mitochondrial matrix, although 15 to 20 % of the 
protein is found in the cytosol (Gupta and Knowlton, 2005). HSP60 facilitates the 
folding and assembly of mitochondrial proteins and the proteolytic degradation of 
misfolded or denatured proteins in an ATP-dependent manner (Parcellier et al., 
2003). The chaperone function of Hsp60 is regulated by Hsp10, which binds to 
Hsp60 and regulates substrate binding and ATPase activity (Bukau and Horwich, 
1998).  
Unlike the ubiquitous Hsp70 and Hsp90 counterparts, members of the small Hsps 
(HO-1 or Hsp32, Hsp27, Hsp25, -crystallin, and Hsp20 chaperones) exhibit 
tissue specific expression and are of special interest to cardiovascular biology 
(Benjamin and McMillan, 1998). These proteins vary in size from 15 to 30 kDa 
and share sequence homologies and biochemical properties such as 
phosphorylation and oligomerisation.  
1.9.2 Molecular chaperones in cellular organelles 
Generally it is thought that molecular chaperones associated with specific 
organelles such as the ER may be of more clinical importance. ER stress and 
alterations in Ca
2+
 homeostasis are associated with apoptotic signalling events. 
Stress stimuli such as anoxia and glucose starvation are known to induce 
expression of members of the Ca
2+
-binding glucose-related family of Hsps such as 
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Grp170, Grp194, and Grp78/BiP (Gething, et al., 1992). Variable levels of 
expression of these Hsps have been reported after experimental ischaemia 
(Nishizawa et al., 1996). However, there is limited information on Grp expression 
and their role in pathological conditions in which abnormal proteins are expressed 
or secreted via the ER-Golgi pathway. 
1.10 Hsps associate with key apoptotic proteins 
Several Hsps have been shown to enhance cell survival by blocking both caspase-
dependent and caspase-independent apoptotic signalling pathways at multiple 
points (Arya et al., 2007; Gill et al., 2006; Parcellier et al., 2003). A summary of 
these pathways is shown on Figure 1.7. Hsp27 binds to cytochrome c, after its 
release from the mitochondria following mitochondrial perturbation, and prevents 
it from binding to Apaf-1, thus blocking downstream cascades which lead to 
caspase-mediated apoptosis (Concannon et al., 2003; Paul et al., 2002; Bruey et 
al., 2000). Hsp27 also binds to procaspase 3, blocking the formation of the 
apoptosome. Additionally Hsp 27 has been shown to bind to Daxx, preventing its 
recruitment to Fas which causes a blockage of this caspase-independent pathway 
(Charette et al., 2000). Daxx is a nuclear protein that translocates to the membrane 
and binds on one end to Fas and at the other to Ask1, triggering caspase-
independent apoptosis. Hsp27 prevents the translocation of Daxx to the membrane 
and its interaction with Fas and Ask1 (Concannon et al., 2003).   
Hsp90 binds to Apaf-1 and prevent it from binding to cytochrome c (Parcellier et 
al., 2003; Pandey et al., 2000). Also, Hsp90 has been shown to interact with RIP-1 
kinase and Akt to promote NF-кB-mediated inhibition of apoptosis (Parcellier et 
al., 2003). Hsp70 prevents oligomerised Apaf-1 from recruiting pro-caspase-9 
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(Beere et al., 2000). Komarova et al. (2004) demonstrated that Hsp70 suppresses 
caspase-dependent apoptotic signalling by binding both caspase-3 and caspase-7 
and preventing their proteolytic maturation. Additionally Hsp70 has been shown to 
suppress JNK activation, thus inhibiting the JNK pathway of apoptosis (Gabai et 
al., 2002; Volloch et al., 2000). Hsp60 and Hsp10 block the release of cytochrome 
c from the mitochondria (Lin et al., 2001) and over-expression of both Hsps has 
been shown to inhibit caspase-3 and modulate Bcl-2 family members to attenuate 
doxorubicin-induced cardiac muscle death (Shan et al., 2003).  
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Figure 1.7: Summary of regulation of apoptosis signalling pathways in 
cardiomyocytes.  
Apoptotic signalling pathways in cardiomyocytes include those initiated by the 
death receptor, mitochondrial stress, and ER stress. These pathways are down-
regulated at several points by antiapoptotic Bcl-2 family members, inhibitors of 
apoptosis (e.g., cFLIP, IAP, and ARC), and heat shock proteins. In contrast, pro-
apoptotic Bcl-2 family members such as Bax, Bad, and Bid, which are activated 
by several factors including calpain and calcineurin, up-regulate apoptosis. Hsp27 
binds to both cytochrome c and procaspase-3, which blocks the formation of the 
apoptosome and downstream signalling events that eventually lead to caspase-
mediated apoptosis. Also, Hsp27 regulates caspase-independent apoptosis through 
its interaction with Daxx (not shown). Hsp70 prevents oligomerised Apaf-1 from 
recruiting pro-caspase-9. Hsp60 and Hsp10 block release of cytochrome c from 
the mitochondria. IAP, inhibitor of apoptosis; cFLIP, cellular FADD-like 
inhibitory protein; Cyt c, cytochrome c (adapted from Gill et al., 2002). 
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1.11 Hsps as potential therapeutic targets to modulate apoptosis 
The preceding sections reviewed how the expression of Hsps varies in response to 
exposure to various cellular stressors. Also reviewed here were the roles of Hsps 
as molecular chaperones and regulators of the apoptotic signalling processes to 
enhance cell survival. This makes the regulation of the expression and the activity 
of Hsps, either by pharmacological or genetic manipulation, a potential tool to 
modulate apoptosis in pathological conditions (Kalmar and Greensmith, 2009; Sõti 
et al., 2005). Therefore, the induction of Hsps in vivo may have several benefits 
and wide ranging clinical applications, for example, in cardio protection, cellular 
defence against stroke and various neurodegenerative diseases. The mechanism(s) 
of preconditioning-induced cytoprotection is not yet fully understood. However, 
preventative procedures such as heat shock- and I/R preconditioning have been 
shown to prevent lethal I/R injury by decreasing intracellular influx of Ca
2+
, 
improving endothelial function, and protecting cardiomyocyte against apoptosis 
(section 1.8).   
1.12 Methods used to active the stress response 
Heat shock is the archetype of the induction of stress proteins (Ritossa, 1962). 
However, whole body or partial hyperthermia is cumbersome and may not be 
feasible in conscious humans hence other methods of inducing expression of stress 
proteins have been devised. 
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1.12.1 Pharmacological methods 
A multi-target pharmacological approach has been adopted to alleviate lethal 
effects of I/R injury. Several pharmacological agents that modulate Hsp expression 
levels by acting as Hsp inhibitors or cellular stress inducers, which transiently 
elevate the level of unfolded proteins inside the cell, are commercially available 
(Table 1.2) 
Table 1.2: Pharmacological modifiers of Hsp action (Sreedhar and Csermely, 
2004). 
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Amphetamine-induced lipolysis elevates body temperature which in turn leads to 
up-regulated Hsp synthesis and improved post-ischemic heart recovery (Maulik et 
al., 1995). Interleukin-6-like cytokine cardiotrophin-1 (CT-1) has been shown to 
induce Hsp synthesis in cultured cardiac cells and that treatment of these cells with 
CT-1 protects them against subsequent exposure to thermal or ischemic stress 
(Stephanou et al., 1998). Herbimycin A, a tyrosine kinase inhibitor, produces 
similar effects in cultured cardiac cells (Morris et al., 1996). Proteasome inhibitors 
up-regulate Hsp synthesis by increasing the amount of misfolded proteins in the 
cell, triggering the stress response (Marcu et al., 2000).  
Bimoclomol, a nontoxic hydroxylamine derivative, induce Hsp synthesis in the 
intact heart by perturbing various membrane structures and helping the release of 
putative lipid-signalling molecules (Vígh et al., 1997). Also, it prolongs the 
binding of HSF1 to the heat shock element on the DNA (Hargitai et al., 2003). 
Similarly, Meng et al. (1996) demonstrated that treatment of rats with 
norepinephrine results in Hsp induction in the heart and protection against 
ischemia when the heart was subsequently perfused ex vivo.  
The identification of pharmacological compounds with the ability to induce stress 
proteins without producing severe side effects could make pharmacological 
induction of stress protein synthesis a viable therapeutic approach. Alternative 
methods may involve the development of small molecules and peptides that mimic 
the in vivo actions of chaperones with therapeutic benefits and their delivery to 
target tissues using biomarkers and nanotechnology. 
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1.12.2 Gene therapy methods 
Unfortunately, several of the above-mentioned pharmacological inducers of Hsps 
are also assoiated with significant side effects, which limits their clinical 
application (Latchman, 2001). Such side effects can be avoided if hsp-genes could 
be efficiently delivered to the heart. Since transgenic procedures are not applicable 
in humans, this will require the development of procedures able to safely and 
effectively deliver stress protein genes to the heart of the individual patient. 
Previously it has been shown that the Hsp70 gene within a plasmid vector can be 
delivered to the heart via intra-coronary infusion of liposome particles containing 
it (Suzuki et al., 1997). The elevated Hsp70 expression produced by this means 
conferred effective protection against subsequent I/R injury. However, the need to 
safely and efficiently deliver stress protein genes to the target tissue remains a 
problem in Hsp-gene delivery to the heart. The possible development of viral 
vector able to safely and efficiently deliver Hsp-genes to the cardiac cells gives 
hope towards the therapeutic application of Hsps in pathological conditions though 
targeted gene delivery.   
1.13 Principles of transcriptional regulation 
Temporal and spatial expression of functionally related genes is regulated in part 
at transcription level. Such genes are co-regulated by the same transcription 
factors. The response to specific environmental and developmental signals is 
mediated by distinct modular and combinational interactions of a set of 
transcription factors binding to their cognate transcription factor binding sites 
typically in close proximity to each other (Cartharius et al., 2005; Diamond et al., 
1990). 
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1.14 Transcriptional regulation of heat shock genes (Hsp-genes) 
The inducible expression of Hsps is regulated at transcriptional level by heat shock 
factors (HSFs) that bind to cognate cis-acting regulatory elements (CARE), known 
as heat shock elements (HSEs), that are located in promoters of heat shock 
responsive genes (Dai et al., 2003; Morimoto, 1998; Wu, 1995; Morimoto et al., 
1992). HSEs are composed of multiple inverted repeats of adjacent 
pentanucleotide 5‟-nGAAn-3‟ motifs (Figure 1.8). 
 
Figure 1.8: Nucleotide sequence of the Hsp70 HSE (nt -130 to -81).  
The grey boxes indicate individual HSF1 binding sites (adapted from Jolly et al., 
2002). 
At present, four different HSFs have been identified in vertebrates and plants, 
HSF1, HSF2, HSF3 and HSF4, whilst only one HSF is expressed in 
Saccharomyces cerevisiae, Caenorhabditis elegans, and Drosophila (Sorger and 
Pelham, 1988; Jedlicka et al., 1997). The four factors have been shown to respond 
differently to various forms of cellular stress (Pirkkala et al., 2001). HSF1 is 
ubiquitously expressed and is the main heat shock transcription factor that is 
activated in response to thermal stress (Rabindran et al., 1991). In non-stressed 
eukaryotic cells, HSF1 is maintained in a transcriptionally inactive, non-DNA 
binding state. Upon exposure to heat shock or other forms of cellular stress, HSF1 
monomers form an activated, DNA-binding trimeric complex (Pirkkala et al., 
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2001; Wu, 1995) which binds to the HSE and induce transcription of stress 
responsive genes (Figure 1.9).  
 
Figure 1.9: General structure and regulatory features of HSFs.  
A schematic representation of HSF1 structural motifs showing the DNA-binding 
domain, hydrophobic heptad repeats (HR-A/B and HR-C), the carboxy-terminal 
transcription activation domain, and the negative regulatory domains that 
influence HSF1 activity. The amino acid residues indicate the relative positions of 
these domains in HSF1. The bottom section shows a schematic of the 
intramolecular negatively regulated monomer that is activated upon exposure to 
stress to form homotrimers with DNA-binding activity (adapted from Morimoto, 
1998). 
 
 
 
 
  
34 
 
 HSF2 is mainly involved in regulation of differential Hsp-gene expression during 
development (Morimoto, 1998; Schuetz et al., 1991). HSF3, which, to date, has 
only been characterised in avian species, behaves like HSF1 (Nakai and 
Morimoto, 1993). HSF4 is expressed in a tissue-specific manner and displays 
constitutive DNA-binding activity (Morimoto, 1998; Nakai et al., 1997; Wu, 
1995). 
1.15 Bioinformatics tools and the principle of transcriptional co-regulation 
Gene expression profiling methods such as microarrays have yielded large 
amounts of data linking genes, through altered RNA levels, to gene expression 
patterns. This offers insight into global gene expression patterns in response to a 
specific stimulus. However the simultaneous detection of altered RNA levels of 
two different genes in response to a single stimulus does not necessarily imply 
that the same pathway regulates both genes. Generally a single stimulus activates 
several pathways simultaneously, leading to coincidental alterations in levels of 
expression of several different genes. Such genes are co-expressed, not co-
regulated. Therefore, there is often a need to distinguish between co-expressed 
and co-regulated genes.  
The information concerning transcriptional regulatory networks responsible for 
the observed expression patterns is not contained within the cDNA sequences 
used to generate the arrays. Regulation of gene expression is determined, to a 
large extent, by the regulatory sequences of the individual genes (promoters and 
enhancers) (Fessele et al., 2002; Werner, 2003). These regions are thus of special 
interest as they govern most aspects of developmental and functional integrity of 
multicellular organisms (Werner, 2001).  
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1.16 Progress in in silico promoter analysis  
Until recently, it was almost impossible to reliably identify transcriptional 
promoters in large DNA sequences (Fickett and Hatzigeorgiou, 1997). Recent 
advances in bioinformatics have made it possible to locate DNA sequences 
corresponding to promoter, even in complex eukaryotic genomes (Scherf et al., 
2002). However, merely locating the promoter sequence is not very informative. 
Additionally, there is need to establish the functional organisation of the 
promoter, what is also referred to as the “anatomy” of the promoter or the 
“context” of the transcription factor binding sites. Typically, promoters are 
composed of functionally defined modular units that enable them to respond to 
specific signalling pathways or induction in a cell- or tissue-specific manner. 
However, in some cases the detailed experimental data on the functional 
organisation of a specific promoter are not available. Fortunately bioinformatics 
tools such as MatInspector and ModelInspector that enable in silico prediction and 
modelling of the functional organisation of the promoter in the absence of 
experimental data are now available (Figure 1.10). Such algorithms cluster co-
regulated genes on the basis of shared promoter modules and provide powerful 
alternatives for elucidating the function of novel genes (Gailus-Durner et al., 
2001; Werner, 2001).  
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Figure 1.10: Graphic output from MatInspector showing the location of various TFBS in the promoter sequences of Hsph1 and 
Cryab. 
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Thus, as evidenced by this literature review, there is a close link between pathways 
leading to apoptosis and stress response and an increasing number of reports have 
shown that stress proteins function at multiple points in the apoptotic signalling 
pathway. Currently available pharmacological regulators of Hsps against fatal 
ischemic/reperfusion heart injury have had limited clinical success and a multi-
target pharmacological approach has been proposed (Yellon and Hausenloy, 
2007).  
A previous study (Gill, 2004) identified 127 genes that are differentially expressed 
in H9c2 cells following heat shock using suppression subtractive hybridization 
(SSH). This included genes that have not previously been associated with the heat 
shock response. However, the application of differential gene expression strategies 
such as SSH is limited by high false positive rate. Therefore there is need to 
validate data generated using these methods. The current study aimed to identify 
novel heat shock elements in H9c2 cells. Functionally related genes such as heat 
shock responsive genes are co-regulated by the same set of transcription factors 
which bind to conserved cognate DNA sequence motifs in the promoter region. 
Therefore the hypothesis was that the promoters of such genes share conserved 
sequence motifs and that the identification of such sequence motifs may enable the 
identification of novel heat shock responsive genes in silico. Potentially such 
genes could have cytoprotective roles and the identification of novel regulatory 
elements in stress response and cytoprotective pathways could provide new 
therapeutic targets against cardiovascular disease.  
Specific aims were to: 
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 Analyse promoter sequences of putative heat shock responsive genes using 
in silico tools. 
 Demonstrate the cytoprotective effect of heat shock preconditioning in 
H9c2 cells against apoptosis. 
 Investigate the expression of putative heat shock responsive genes in H9c2 
cells following heat shock treatment using real-time quantitative reverse 
transcription polymerase chain reaction (qRT-PCR).  
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CHAPTER 2.0: MATERIALS AND METHODS 
2.1 General chemicals and suppliers 
Agarose                                                           Promega 
Ammoniun persulphate (AMPS)                            Promega 
Ampicillin                                                              Roche   
APOPercentage
TM
 assay dye                                       BD Biosciences 
Bacteriological agar                                                   Merck 
Boric acid                                                                   Merck 
Bovine serum albumin (BSA)                                    Roche  
Bromophenol blue                                                      Sigma-Aldrich 
Buffer saturated phenol                                               Invitrogen 
Cesium chloride                                                         Roche 
Chloroform                                                                  BDH 
Coomassie Brilliant Blue R 250                                 Sigma-Aldrich 
Diethyl Pyrocarbonate (DEPC)                                  Sigma-Aldrich  
Dimethyl sulphoxide (DMSO)                                  Sigma-Aldrich 
DTT (Dithiothreitol)                                                  Roche 
EDTA (Ethylene diamine tetra acetic acid)              Merck 
Ethanol                                                                       Sigma-Aldrich 
Ethidium bromide                                                    Promega 
G418-sulphate                                                          Promega 
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Glucose                                                                      Merk 
Glacial acetic acid                                                     Merck 
Glycine                                                                         Sigma-Aldrich 
Isoamyl alcohol                                                         Merck 
Metafectene
TM
 transfection reagent                              Biontex Laboratories 
Methanol                                                                         Merck 
Penicillin Sigma-Aldrich 
Potassium acetate                                                      Merk 
Propan-2-ol                                                                 Merk 
SDS (Sodium dodecyl sulphate)                                  Promega 
SAP (Shrimp alkaline phosphatase)                         Fermentas                
Sodium acetate                                                           Merck 
Sodium chloride                                                          Merck 
Sodium hydroxide                                                       Merck 
TEMED (N, N, N΄, N΄-Tetra methylethylene-diamine)  Promega 
Tris [hydroxymethyl] aminomethane                      Merck 
TRIzol
®
 reagent                                                         Invitrogen Life Sciences 
Trypsin                                                                        Invitrogen Life Sciences 
Tryptone                                                                     Merck 
Xylene cyanol                                                           BDH 
Yeast extract                                                             Merck 
Zeocin                                                                        Invitrogen Life Sciences 
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The chemicals used were all of A or equivalent grade. 
2.2 Kits 
Cell culture media GIBCO 
First strand cDNA synthesis kit                                   Promega                                          
LightCycler
®
 FastStart DNA Master SYBR Green 1     Roche Applied Sciences 
Wizard  Plus Minipreps DNA Purification System   Promega 
Wizard  SV Gel and PCR Clean-Up System        Promega 
2.3 Enzymes 
BamHI, NotI Fermentas 
Proteinase K                                                              Roche 
RNase A                                                                     Roche 
DNase Roche 
T4 ligase                                                                    Fermentas 
2.4 General stock solutions and buffers 
2x Sample buffer: 100 mM Tris-HCl (pH 6.8), 25 % glycerol, 0.01 % BPB, 50 
mM DTT. *stored at -20
 o
C 
5x Running buffer: 25 mM Tris-HCl, 0.95 M glycine, 1 % SDS)  
6x Glycerol BPB gel loading buffer: 30  Glycerol, 0.25  Bromophenol blue 
and 0.25  Xylene cyanol 
10x MOPS: 0.2 M Na-MOPS, 50 mM Na-Acetate, 10 mM EDTA (pH 7.0) 
adjusted with acetic acid 
10x Phosphate buffered saline (PBS): 137 mM NaCl, 2.7 mM KCl, 8 mM 
Na2HPO4 and 1.5 mM KH2PO4, pH 7.4  
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10x TAE: 0.4 M Tris-acetate and 0.01 M EDTA, pH 8 
10x TBE: 0.9 M Tris-HCl, 0.89 M Boric acid, and 25 mM EDTA, pH 8.3. This 
stock solution was diluted 10 times for agarose gel electrophoresis 
Ammonium persulphate: A 10  stock solution was prepared in deionised 
water. This solution is stored at 4 
o
C 
Ampicillin: A 100 mg/ml stock solution was prepared in deionised water. This 
solution was then filter-sterilised using a 0.22 micron filter and stored at -20 
o
C 
Blocking solution: 1-5  fat free milk powder dissolved in 1X TBS or TBST 
Coommassie staining solution: 0.25 g Coommassie Brilliant Blue R 250, 45  
(v/v) methanol, 5  (v/v) acetic acid and 60  (v/v) dH2O 
Destaining solution: 30  (v/v) Methanol, 10  (v/v) Acetic acid and 60  (v/v) 
dH2O 
Digestion buffer (for DNA extraction from cultured mammalian cells): 100 
mM NaCl, 10 mM Tris-HCl; pH 8.0, 25 mM EDTA; pH 8.0, and 0.5  SDS. 
Proteinase K was added to a final concentration of 0.1 mg/ml just before use 
GTE: 50 mM Glucose, 50 mM Tris-HCl, 10 mM EDTA, pH 8.0 
Luria agar (L agar): 10 g/l Tryptone, 5 g/ml Yeast extract, 5 g/ml NaCl and 14 
g/ml Bacteriological agar, antibiotic added as required 
Luria broth (L broth): 10 g Tryptone, 5 g/ml Yeast extract and 5 g/ml NaCl 
Lysis buffer: PBS containing 1  Triton X-100 
Lysis solution: 200 mM NaOH and 1  SDS (w/v) 
Neutralisation solution: 3 M Potassium acetate, pH 5.0 
Phenol/Chloroform/Isoamyl alcohol: 25 parts Tris-saturated phenol, 24 parts 
chloroform, 1 part isoamyl alcohol 
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RIPA buffer: 50 mM Tris-HCl (pH 7.4), 150 mM NaCl, 1   (v/v) Triton X-100, 
1  deoxycholate, 0.1  SDS, 5 mM EDTA, 1  (v/v) protease inhibitors. 
Protease inhibitors were added just before use 
RNase A (DNase-free): A 20 mg/ml stock solution was prepared in a buffer 
containing 0.1 M sodium acetate and 0.3 mM EDTA (pH 4.8, adjusted using acetic 
acid). This solution was boiled for 15 minutes and rapidly cooled by placing it in 
ice water. The solution was then dispensed into aliquots and stored at -20 
o
C 
Separating buffer: 1.5 M Tris-HCl, pH 8.8 
Stacking buffer: 0.5 M Tris-HCl, pH 6.8 
TE: 10 mM Tris-HCl, 1 mM EDTA, pH 7.4- autoclaved 
Transfer buffer (Western blotting): 25 mM Tris-HCl, 192 mM glycine, 20% 
methanol. *The buffer was prepare fresh and kept ice cold 
Transformation buffer 1 (Tfb1): 30 mM potassium acetate, 50 mM manganese 
chloride, 0.1 M potassium chloride, 6.7 mM calcium chloride and 15 % glycerol 
(v/v)- filter-sterilised 
Transformation buffer 2 (Tfb2): 9 mM MOPS, 10 mM potassium chloride, 50 
mM calcium chloride and 15 % glycerol (v/v)- filter-sterilised 
TBS: 50 mM Tris-HCl, 150 mM NaCl (adjust pH with HCl and make 1x working 
solution in dH2O) 
TBST: 0.1% (v/v) Tween-20, 1x TBS 
TYM: 20 g/l Tryptone, 5 g/l Yeast extract, 3.5 g/l NaCl and 2 g/l MgCl2. The 
broth was sterilised by autoclaving before use  
All solutions were made using deionised water unless otherwise stated.  
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2.5 Bacterial culture 
2.5.1 Bacterial strain 
Escherichia coli strain MC1061 (Casadaban and Cohen, 1980) was used in all 
transformation procedures to clone plasmid DNA. 
2.5.2 Culturing MC1061 
The bacterium was plated on L agar and grown in L broth with or without 
ampicillin as per experimental requirements. To select for E. coli containing 
ampicillin resistant plasmid, transformed cells were plated on L agar with 
ampicillin at 100 µg/mL final concentration. Selection was maintained during 
growth in liquid cultures by including the antibiotic at the same concentration. All 
bacterial cultures were grown at 37 
o
C.  
2.5.3 Storage of bacterial strain and clones 
Glycerol stocks were prepared directly from overnight cultures, grown under 
antibiotic selection pressure, by adding an equal volume of 80  sterile glycerol 
and stored at -80 
o
C. 
2.6 Cloning vector 
2.6.1 pcDNA3.1(+)/zeocin 
The mammalian expression vector, pcDNA3.1(+)/zeocin (Invitrogen, USA), was 
used to clone the full length coding sequences of Atic, cytoplasmic poly(A)-
binding protein (Pabpc1) and Hsp27. pcDNA3.1(+) is a 5.4 kb vector derived 
from pcDNA3 which is designed for high level stable and transient expression in 
mammalian cells. It contains a cytomegalovirus immediate-early (CMV) 
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promoter, a multiple cloning site (MCS) in a forward orientation, zeocin 
resistance gene for selection of stable cell lines and universal T7 forward and 
BGH reverse primers flanking the MCS (Figure 2.1).  
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Figure 2.1: Restriction maps of pcDNA3.1 vectors and the MCS of pcDNA3.1(+) 
(adapted from www.google.com). 
(a) Restriction maps of both pcDNA3.1(+) and pcDNA3.1(-). Only pcDNA3.1(+) 
carrying the zeocin resistance gene was used in all cloning experiments. 
(b) The DNA sequence of the MCS of pcDNA3.1(+) showing restriction enzymes 
recognition sequences and the positioning of universal T7 and BGH primer 
sequences.  
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(a) 
 
(b) 
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2.7 Preparation of E. coli competent cells for transformation 
A glycerol stock of the MC1061 strain was used to streak an L agar plate 
containing 10 mM MgCl2 and incubated for 16 hours at 37 
o
C. Following 
incubation, a single colony from the plate was used to inoculate 20 mL TYM broth 
and grown at 37 
o
C with vigorous shaking until an optical density (OD) of 0.2 at 
550 nm was reached. The culture was then transferred to 100 mL fresh TYM broth 
and incubated at 37 
o
C until an OD of 0.2 at 550 nm was reached. The culture was 
transferred into a 2 L flask and 400 mL of fresh TYM broth were added to the 
culture followed by further growth under the same conditions until an OD between 
0.4 and 0.6 at 550 nm was reached. The culture was then rapidly cooled by gently 
swirling the flask in ice water, transferred into a 250 mL centrifuge tube and 
centrifuged at 6 000 x g for 10 minutes at 4 
o
C in a Beckman J2-21 rotor. The 
supernatant was discarded and the pellet re-suspended in 250 mL of ice-cold Tfb1 
buffer followed by incubation on ice water for 30 minutes. After incubation the 
cells were recovered by centrifugation at 6 000 x g for 10 minutes at 4 
o
C. The 
supernatant was discarded and the pellet gently re-suspended in 50 mL of ice-cold 
Tfb2 buffer. Re-suspended cells were then dispensed in 500 mL aliqouts and 
rapidly frozen in liquid nitrogen. Competent cells were stored at -80 
o
C. 
2.8 Bacterial transformation 
A 300-500 L aliquot of MC1061 competent cells were recovered from -80 
o
C and 
partially thawed on ice. 50 L of cells were then carefully added onto 10 µL (1.0-
10ng) of the plasmid DNA solution in a 1.5 ml tube, gently mixed by tapping the 
bottom of the tube and incubated on ice for 20 minutes. The bacterial cells were 
then heat-shocked by placing the tubes in a water bath equilibrated at 42 
o
C for 45 
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seconds after which they were immediately placed on ice and incubated for 5 
minutes. Thereafter, 950 L of pre-warmed sterile L broth containing no 
antibiotics was added and the mixture incubated on a shaker for 1 hour 30 minutes 
at 37 
o
C to allow for the expression of the antibiotic resistance marker. 50 L of 
this transformed culture was then plated on nutrient L agar plates containing 100 
g/mL amplicillin. Plates were incubated overnight at 37 
o
C. 
2.9 Preparation of plasmid DNA 
Plasmid DNA was isolated from bacterial cells based on the alkaline lysis 
procedure (Birnboim and Dolly, 1979). 
2.9.1 Small-scale preparation of plasmid DNA 
Five mL of L broth containing 100 g/mL amplicillin were inoculated with a 
single colony of transformed E. coli and cultured overnight at 37
 o
C with vigorous 
shaking. Glycerol stocks of the transformed E. coli were prepared from the 
overnight cultures as described in section 2.5.3. The rest of the culture was 
centrifuged at 10 000 x g for 10 minutes at 4
o
C in a Beckman J2-21centrifuge. The 
supernatant was discarded and the cell pellet re-suspended in 300 L GTE 
containing 100 g/mL freshly prepared RNase A. The cell suspension was then 
transferred to a 1.5 mL tube and incubated on ice for 5 minutes. Cells were then 
lysed by adding 300 L of lysis solution, carefully mixed by 4 inversions and 
incubated on ice for 5 minutes. After incubation 300 L neutralisation solution 
were added to neutralise the alkali followed by gentle mixing by 4 inversions. The 
resultant mixture was further incubated on ice for 5 minutes and then centrifuged 
at 14 000 x g for 10 minutes at 4 
o
C. The supernatant were transferred to a sterile 
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1.5 ml tube and 450 L of propan-2-ol added, mixed gently by inversion and 
placed at -20
o
C for at least 30 minutes to precipitate the plasmid DNA. After 
incubation the samples were centrifuged at 10 000 x g for 20 minutes at room 
temperature. The supernatant was discarded and the pellet re-suspended in 500 L 
TE buffer. An equal volume of phenol:chloroform:isoamyl alcohol was added 
followed by centrifugation at 10 000 x g for 5 minutes at room temperature. The 
upper aqueous phase containing the DNA was transferred to a clean 1.5 ml tube 
and DNA precipitated by adding 0.1 volumes of 3M sodium acetate and 2.5 
volumes of ethanol. This was incubated for 30 minutes at -20
o
C and the DNA was 
recovered by centrifugation at 10 000 x g for 10 minutes at room temperature. The 
supernatant was decanted and the pellet washed with 70  ethanol. The plasmid 
DNA was again recovered by centrifugation at 10 000 x g for 5 minutes at room 
temperature. The pellet was air-dried and re-suspended in 50 L TE buffer, 
increasing the volume to 100 L if the pellet was too viscous. The DNA was 
quantified by measuring OD at 260 nm using a ND 1 000 spectrophotometer (one 
OD260 unit of double stranded DNA is equivalent to 50 ng/ L). 
2.9.2 Large-scale recovery of plasmid DNA from transformed MC1061 E. coli 
bacterial cells by double cesium chloride/ethidium bromide fractionation 
This method was used to produce high quality plasmid DNA for transfection of 
eukaryotic cells. 500 mL of L broth were inoculated with 10 µL of the plasmid-
containing bacterial glycerol stock and grown overnight at 37 
o
C. Bacterial cells 
were harvested by centrifugation at 4 500 x g for 10 minutes at 4 ºC. The 
supernatant was discarded and the pellet was re-suspended in 4 mL GTE buffer 
containing 100 g/mL RNase A followed by incubation at 37 
o
C for 2 hours. The 
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cells were then lysed by adding 8 mL of lysis solution, mixed carefully by 
inverting the tube six times and incubation on ice for 10 minutes. After incubation 
6 ml of 3.5 M potassium acetate (pH 5.5) were added to neutralise the alkali, 
mixed gently by inversion and incubated on ice for 10 minutes. The precipitate of 
cell debris, chromosomal DNA and SDS was removed by centrifugation at 10 000 
x g for 15 minutes at 4 ºC. The resulting supernatant was filtered through glass 
wool to remove particulate material and nucleic acids were precipitated by adding 
0.8 volumes of propan-2-ol followed by incubation at -20 ºC for 20 minutes. 
Nucleic acids were then recovered by centrifugation at 10 000 x g for 10 minutes 
at 4 ºC and re-suspended in 5 ml TE. Plasmid DNA was separated from RNA by 
double CsCl/ethidium bromide fractionation. 
Thereafter, 500 µL ethidium bromide and 5.75g cesium chloride were added to the 
5 mL solution containing resuspended nucleic acids and thoroughly mixed to give 
a final density of 1.61 g/mL. If necessary the density was adjusted using TE and 
cesium chloride-saturated TE. The mixture was centrifuged at 10 000 x g for 10 
minutes at -20 ºC. The resulting pellet was mainly RNA and the DNA remained in 
the supernatant which was recovered using a syringe, filtered through glass wool, 
and the density re-adjusted using TE and cesium chloride-saturated TE to give a 
final density of 1.61 g/mL. 5 mL of the supernatant were transferred to a 
Quickseal tube and centrifuged at 55 000 x g for 18 hours at 20 ºC in a Beckman 
Coulter Optima
TM
 L-80 XP ultracentrifuge (Beckman Coulter, USA) using an 
NV65.2 rotor. After centrifugation the plasmid DNA band was visualised using a 
360 nm UV illuminator and recovered using a syringe.  
 
 
 
 
  
52 
 
An equal volume of sodium chloride-saturated isopropanol was added followed by 
centrifugation at 4 500 x g for 5 minutes at room temperature to remove the 
ethidium bromide from the DNA. The top ethidium bromide layer was aspirated 
and the extraction repeated at least four times, discarding the coloured top layer 
each time. Two volumes of water and one volume of propan-2-ol were added, 
mixed by vortexing and incubated for 30 minutes at -20 
o
C. The DNA was then 
recovered by centrifugation at 10 000 x g for 15 minutes at room temperature and 
the resulting pellet was air-dried and re-suspended in TE. The concentration was 
determined by measuring absorbance at λ260 nm and the DNA stored at -20 ºC. 
2.10 Restriction enzyme digestion of plasmid DNA 
To enable ligation of a DNA fragment into the MCS of pcDNA3.1(+), double 
restriction enzyme digestion of the vector was carried out using NotI and BamHI 
FastDigest  restriction enzyme in a compatible 1x FastDigest  buffer (Fermentas 
Life Sciences, USA) according to the manufacturer‟s instructions. Approximately 
1 g of plasmid DNA was digested with 10 units of each restriction enzyme in a 
50 µl reaction (Table 2.1). 
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Table 2.1: Restriction enzyme digestion mix. 
One µg of DNA was double-digested using NotI and BamHI FastDigest  
restriction enzyme in 1x FastDigest  buffer.  
REAGENT VOLUME (µL) 
Nuclease-free water - 
10x FastDigest
 
buffer 5 
FastDigest
  
enzymes (10 U) 2 
DNA (1 µg) - 
TOTAL VOLUME 50 
 
The digest mixture was incubated for 30 minutes on a heating block at 37 
o
C. 
After incubation restriction enzymes were inactivated by incubating for 5 minutes 
at 80 
o
C. The digested plasmid DNA and PCR products were extracted by 
electrophoresis on a 1  agarose gel. 
2.11 Dephosphorylation of digested plasmid DNA 
To prevent re-circularisation of a partially digested, empty vector during ligation, 
the digested vector was dephosphorylated using shrimp alkaline phosphatase 
(SAP) (Fermentas Life Sciences, USA). SAP catalyses the release of 5΄ and 3΄ 
phosphate groups from DNA and RNA. The dephosphorylation reaction was set 
up as shown on Table 2.2 and incubated for 1 hour on a heating block at 37 
o
C. 
After incubation the SAP was inactivated by incubating for 15 minutes at 65 
o
C. 
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Table 2.2: Dephosphorylation reaction set-up using shrimp alkaline phosphatase 
(SAP).                
REAGENT VOLUME (µL) 
Nuclease-free water - 
10x SAP reaction buffer 5 
DNA (100 ng) - 
SAP (10 U) 1 
TOTAL VOLUME 50 
 
2.12 Design of cloning primers 
Primers were designed to amplify the full-length coding sequence (CDS) of three 
genes from the Rattus norvegicus genome; Atic (Accession number: 
NM_031014), cytoplasmic Poly(A)-binding protein (Pabpc1) (accession number: 
NM_008774) and Hsp27 (accession number NM_031970.3) 
(http://www.ncbi.nlm.nih.gov/). To enable digestion of the PCR product with 
restriction enzymes, the recognition sequence for BamHI was designed into the 5΄ 
end of the forward primers and that of NotI was designed into the 5΄ end of the 
reverse primers (Table 2.3). Additionally, a Kozak translation initiation sequence 
and an ATG start codon, (G/ANNATGG) were designed into the 5΄ end of the 
forward primer where possible for proper initiation of translation (Kozak, 1991; 
Kazak, 1990). Figures 22, 23 and 24 show the full coding sequences for Atic, 
Pabpc1 and Hsp27 respectively, and the positioning of the forward and reverse 
primers. 
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Table 2.3: Primers that were designed to amplify full-length coding sequences of Atic (1 779 bp), Pabpc1 (1 911 bp) and Hsp27 (618 bp) 
by PCR.  
Underlined sequences represent restriction recognition sequences for BamHI and NotI in the forward and reverse primers respectively. Bold 
letters represent the Kozak sequence inserted at the 5΄ end of the forward primers to enable proper initiation of translation. 
Gene Forward primer (5΄-3΄) Reverse primer (5΄-3΄) Expected size (bp) 
Atic GTGAGGATCCGACATGGCTTCCTCCCAGCTTG ATAAGCGGCCGCTCAGTGGTGGTGGAAGAGACGC 1 779 
Pabpc1 CTAAGGATCCGACATGAACCCCAGCGCCCC CAGAGCGGCCGCTTAGACAGTTGGAACACCAGT 1 911 
Hsp27 CTGAGGATCCGACATGACCGAGCGCCGCGTGC ACTAGCGGCCGCCTACTTGGCTCCAGACTGTTC 618 
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ATGGCTTCCTCCCAGCTTGCCCTGTTCAGTGTGTCTGACAAAACTGGCCTCGTGGAATTTGCCAGA
AACCTCGCGTCTCTTGGTTTGAGTTTGGTCGCTTCTGGAGGCACGGCAAAAGCGATCAGGGATGCT
GGCCTGGCAGTGAGAGATGTGTCTGAGCTAACTGGGTTCCCTGAAATGTTAGGGGGGCGTGTGAAA
ACCTTGCATCCTGCAGTCCATGCTGGAATCTTAGCACGCAATATTCCAGAAGATGCTGCTGACATG
GCCAGGCTTGATTTCAACCTCATAAGAGTTGTTGTCTGTAACCTGTACCCGTTCGTGAAGACTGTG
GCTTCTCCAGATGTAACCGTTGAGGCAGCTGTTGAGCAAATTGACATTGGTGGCGTGACCTTACTG
AGAGCTGCAGCCAAAAACCATGCTCGAGTGACAGTTGTGTGTGAGCCAGAGGACTATGGTGCGGTG
GCTGCAGAGATGCAGGGCTCTGGTAATAAGGACACCTCCCTGGAGACCAGGCGCCACTTGGCATTG
AAGGCATTCACGCATACCGCTCAATATGATGAAGCGATTTCGGATTACTTCAGGAGACAGTACAGT
AAAGGAATTTCTCAGATGCCCTTGAGGTATGGGATGAACCCCCATCAGACTCCTGCCCAGCTGTAT
ACACTGAAGCCCAAGCTTCCCATCACAGTTCTCAACGGAGCCCCAGGATTCATAAACCTCTGCGAT
GCTTTGAATGCCTGGCAGCTGGTGACAGAGCTGAGAGGAGCAGTAGACATTCCAGCTGCGGCGTCT
TTCAAGCACGTCAGCCCAGCAGGTGCTGCTGTTGGGGTTCCACTCAGTGAGGACGAAGCCAGAGTC
TGCATGGTCTATGACCTCTATCCGACCCTCACGCCCCTGGCCATTGCATATGCAAGAGCAAGAGGA
GCTGATAGGATGTCTTCATTTGGTGATTTTGTTGCATTATCTGATGTTTGTGATGTCCCAACTGCA
AAAATTATCTCCAGAGAAGTGTCAGATGGTATTGTTGCCCCAGGATATGAGGAAGAGGCCTTGAAA
ATACTTTCTAAAAAGAAAAATGGAAGCTACTGTGTTCTTCAGATGGACCAGTCCTACAAACCGGAT
GAAAATGAAGTTCGAACGCTCTTTGGTCTTCGTTTAAGCCAGAAGAGAAATAATGGTGTTGTTGAC
AAGTCGTTGTTTAGCAATATTGTCACCAAGAATAAAGATCTGCCGGAATCTGCTCTCCGAGACCTC
ATTGTCGCCACCATCGCTGTCAAGTATACTCAGTCTAATTCGGTGTGCTATGCCAAGGACGGGCAG
GTTATTGGCATCGGAGCAGGACAGCAGTCTCGGATACACTGTACACGCCTTGCAGGTGATAAGGCA
AACTCTTGGTGGCTTCGGCACCATCCACGAGTGCTTTCCATGAAGTTTAAAGCTGGGGTGAAGAGA
GCAGAAGTCTCCAATGCCATCGATCAGTATGTGACCGGCACCATTGGTGAGGGTGAAGACCTGGTG
AAATGGAAAGCACTGTTTGAAGAGGTTCCTGAGTTACTCACTGAGGCGGAGAAGAAGGAATGGGTG
GACAAGCTGAGTGGCGTGTCTGTCAGTTCCGATGCTTTCTTTCCTTTCAGGGATAATGTAGACCGA
GCGAAAAGGAGTGGTGTGGCCTACATTGTTGCTCCATCCGGATCTACTGCTGACAAGGTTGTGATC
GAGGCGTGTGACGAGCTGGGGATCGTGTTGGCTCATACAGATCTGCGTCTCTTCCACCACTGA 
 
Figure 2.2: Full coding sequence of Atic showing the position of the forward 
primer (yellow) and the reverse primer (purple). 
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ATGAACCCCAGCGCCCCCAGCTACCCCATGGCCTCTCTGTACGTGGGGGACCTGCACCCCGACGTG
ACCGAGGCGATGCTCTACGAGAAGTTCAGCCCGGCCGGGCCCATCCTCTCCATCCGGGTCTGCAGG
GACATGATCACCCGCCGCTCCTTGGGCTACGCGTACGTGAACTTCCAGCAGCCGGCGGACGCGGAA
CGTGCTTTGGACACCATGAATTTTGATGTTATAAAGGGCAAGCCAGTACGCATCATGTGGTCTCAG
CGTGATCCATCACTTCGCAAAAGTGGAGTAGGCAACATATTCATTAAAAATTTGGACAAATCCATC
GACAATAAAGCACTATATGATACGTTTTCTGCGTTTGGTAACATCCTTTCATGTAAGGTGGTTTGT
GATGAAAATGGCTCCAAGGGCTATGGATTTGTACACTTTGAAACACAGGAAGCAGCTGAAAGAGCT
ATTGAAAAAATGAATGGGATGCTTCTAAATGATCGTAAAGTGTTTGTTGGACGATTTAAATCTCGG
AAGGAACGAGAAGCAGAGCTTGGAGCCAGGGCAAAGGAGTTCACCAATGTTTACATCAAGAACTTT
GGAGAAGACATGGATGATGAGCGCCTTAAGGAACTCTTTGGCAAGTTTGGGCCTGCCTTAAGTGTG
AAAGTAATGACAGATGAAAGTGGAAAATCCAAAGGATTTGGATTTGTAAGCTTTGAAAGGCATGAA
GATGCGCAGAAAGCTGTGGATGAGATGAATGGGAAGGAGCTCAATGGAAAACAGATTTATGTTGGA
CGAGCTCAGAAAAAAGTGGAACGGCAGACGGAACTTAAGCGCAAATTTGAGCAGATGAAGCAAGAT
AGGATCACCAGATATCAGGGTGTGAACCTTTATGTGAAAAATCTTGATGACGGGATTGATGATGAG
CGTCTCCGGAAGGAGTTTTCTCCGTTTGGTACAATCACCAGTGCAAAAGTAATGATGGAGGGTGGG
CGCAGCAAAGGGTTTGGTTTTGTATGTTTCTCATCCCCTGAAGAAGCCACTAAAGCAGTTACAGAG
ATGAATGGTAGAATTGTGGCCACGAAGCCACTGTATGTAGCTTTAGCTCAGCGCAAAGAAGAGCGC
CAGGCTCACCTCACTAACCAGTATATGCAGAGGATGGCAAGTGTACGAGCTGTGCCCAACCCCGTG
ATCAACCCCTACCAGCCAGCACCTCCTTCAGGTTACTTCATGGCAGCTATCCCACAGACTCAGAAC
CGTGCTGCATACTATCCTCCTAGCCAAATTGCTCAACTAAGACCAAGTCCTCGCTGGACTGCTCAG
GGTGCCAGACCTCATCCATTCCAGAATATGCCCGGTGCTATCCGCCCAGCTGCTCCTAGACCACCA
TTTAGTACGATGAGACCAGCTTCCTCACAGGTTCCACGAGTCATGTCAACACAGCGTGTTGCTAAC
ACATCAACACAGACAATGGGTCCACGTCCTGCAGCTGCTGCTGCTGCAGCCACTCCTGCTGTCCGC
ACCGTTCCCCAGTATAAATATGCTGCGGGAGTCCGCAATCCCCAGCAACATCTTAATGCACAGCCA
CAAGTTACCATGCAACAGCCTGCTGTTCATGTGCAAGGTCAAGAACCTTTAACTGCTTCCATGTTG
GCATCTGCGCCCCCGCAAGAGCAGAAGCAAATGTTGGGTGAACGGCTGTTTCCTCTTATCCAAGCC
ATGCACCCTTCTCTTGCTGGTAAAATCACTGGCATGCTGTTGGAGATTGATAACTCAGAATTACTT
CACATGCTCGAGTCTCCAGAGTCTCTCCGCTCAAAGGTTGATGAAGCTGTAGCTGTACTACAAGCC
CACCAAGCGAAAGAGGCTGCCCAGAAAGCAGTGAACAGTGCCACTGGTGTTCCAACTGTCTAA 
 
Figure 2.3: Full coding sequence of Pabpc1 showing the position of the forward 
primer (yellow) and the reverse primer (purple). 
ATGACCGAGCGCCGCGTGCCCTTCTCGCTACTGCGGAGCCCCAGCTGGGAGCCGTTCCGGGACTGG
TACCCTGCCCACAGCCGCCTCTTCGATCAAGCTTTCGGGGTGCCTCGGTTTCCCGATGAGTGGTCT
CAGTGGTTCAGCTCCGCTGGTTGGCCCGGCTATGTGCGCCCTCTGCCCGCCGCGACCGCCGAGGGC
CCCGCAGCAGTGACCCTGGCCCGGCCGTTCAGCCGGGCGCTCAACCGGCAACTCAGCAGCGGTGTG
TCAGAGATCCGACAGACGGCCGATCGCTGGCGCGTGTCCCTGGACGTCAACCACTTCGCTCCTGAG
GAGCTCACAGTGAAGACCAAGGAAGGCGTGGTGGAGATCACTGGCAAGCACGAAGAAAGGCAGGAT
GAACATGGCTACATCTCTCGGTGCTTCACCCGGAAATACACGCTCCCTCCAGGTGTGGACCCCACC
TTGGTGTCCTCTTCCCTGTCCCCTGAGGGCACACTCACGGTGGAGGCTCCGCTGCCCAAAGCAGTC
ACACAATCAGCGGAGATCACCATTCCGGTCACTTTCGAGGCCCGTGCCCAAATTGGAGGCCCAGAG
TCGGAACAGTCTGGAGCCAAGTAG 
Figure 2.4: Full coding sequence of Hsp27 showing the position of the forward 
primer (yellow) and the reverse primer (purple). 
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2.13 Amplification of target fragments by PCR 
Atic, Pabpc1 and Hsp27 full-length coding sequences were amplified by PCR 
under optimum conditions from first-strand cDNA synthesised from RNA 
extracted from H9c2 cells. PCR reactions were carried out in 1x reaction buffer 
using 100 ng of cDNA, 0.5 µM of each dNTP, 0.5 µM of the forward and reverse 
gene-specific primers, 2.5 mM MgCl2 and 0.2 U ExSel Taq DNA polymerase 
(Invitrogen, USA), in a final reaction volume of 50 µL (Table 2.4). 
 
 
 
 
  
59 
 
Table 2.4: PCR components.  
REACTION COMPONENT VOLUME (µL) 
Nuclease-free water 28.1 
10x reaction buffer 5.0 
MgCl2 (50 mM stock) 2.5 
dNTPs (5µM stock) 2.0 
Forward primer (5µM stock) 5.0 
Reverse primer (5µM stock) 5.0 
ExSel Taq polymerase (0.2 U) 0.4 
cDNA (100 ng/µl) 2.0 
TOTAL VOLUME 50.0 
 
The PCR reaction   mixture was cycled through a pre-optimised PCR program 
shown below:   
94 
o
C for 2 min (Initial activation step) 
94 
o
C for 1 min (Denaturation step) 
*(Tm) for 0.5 min (Annealing step)                      40 cylcles 
72 
o
C for 1 min (Extension step) 
72 
o
C for 10 min (Final extension step) 
*Tm for Atic = 63.8 
o
C, Pabp = 64 
o
C and Hsp27 = 66 
o
C. 
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2.14 Agarose gel electrophoresis of DNA 
DNA was size fractionated by agarose gel electrophoresis on 1 or 2  agarose gels 
containing 0.5 µg/mL ethidium bromide. Each DNA sample was mixed with 6x 
glycerol BPB gel-loading buffer before loading onto the gel. Appropriate DNA 
size markers were loaded alongside the samples to enable estimation of the size of 
the DNA fragments. Electrophoresis was carried out at 100 V in 1x TBE or TAE 
electrophoresis buffer and the DNA was visualised with shortwave UV light on a 
trans-illuminator and gel images captured using the Sony UVP image Store 5000 
photographic system. 
2.14.1 DNA molecular weight markers 
Two DNA molecular weight markers were used; MassRuler
TM
 DNA ladder mix, 
ready to use and GenRuler
TM
 1kb plus DNA ladder (Fermentas Life Sciences, 
USA). These markers were used to estimate DNA sizes between 0.6 to 6.0 kb 
(Figure 2.5).                                                
 
Figure 2.5: DNA molecular weight markers that were used to estimate the size of 
DNA fragments. 
MassRulerTM DNA ladder mix GenRulerTM 1kb plus DNA ladder 
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2.14.2 Agarose gel purification of DNA 
This method was used to purify both PCR fragments and the digested vector for 
use in a ligation reaction. A small volume of the sample to be purified was loaded 
onto a “marker lane” and the rest of the sample loaded onto “purification lanes” on 
the same 1 % agarose gel. A size marker was loaded alongside the “marker lane” 
and electrophoresis carried out as described in section 2.14. A piece of the gel 
containing the DNA size marker and the “marker lane” was then separated from 
the rest of the gel and visualised using a hand-held UV lamp (365 nm). The 
position of the band of interest was excised using a blade and the gel aligned with 
the other piece containing the “purification lanes” without exposing the latter to 
UV. The fragment of interest was then excised from the “purification lanes” using 
a sterile blade and placed into a 1.5 mL tube and weighed. DNA was purified from 
the agarose using the Wizard® SV Gel and PCR Clean-up system (Promega, 
USA) according to the manufacturer‟s instructions. The DNA was eluted from the 
spin column using 50 L DNase-free water and quantified on a ND 1 000 
spectrophotometer.  
2.14.3 Restriction enzyme digestion of PCR fragments 
500 ng of PCR product were digested with appropriate restriction enzymes as 
described in section 2.10. DNA was then purified on a 1 % agarose gel as 
described in section 2.14.2 and used in a ligation reaction.  
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2.15 Construction of expression vectors 
The digested PCR product was ligated into pcDNA3.1(+) using T4 ligase 
(Fermentas, USA) to generate Atic, Pabpc1 and Hsp27 expressing constructs 
(Table 2.5). The amount of insert required for each ligation reaction was 
calculated according to the equation: 
ng vector x kb size of insert/kb size of vector x insert:vector molar ratio = ng 
of insert 
                                                                                               (Promega, USA) 
Table 2.5: Components of the ligation reaction.               
LIGATION COMPONENT VOLUME (µL) 
Nuclease-free water - 
10x ligation buffer 5 
Vector (50 ng) - 
Insert (30 ng) - 
T4 ligase (10 U) 1 
TOTAL VOLUME 50 
 
The ligation mixtures were then placed at 4 
o
C for 24 hours.  The ligated 
recombinant plasmid DNA was used to transform competent MC1061 bacterial 
cells as described in section 2.8. Transformed bacterial cells were grown on L agar 
at 37 
o
C overnight and positive clones screened by colony PCR as described in 
section 2.16. 
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2.16 Colony PCR 
To screen bacterial colonies for positive clones, part of the colony was suspended 
in 10 L of sterile water and 2 L of this suspension was used as template in a 
PCR reaction as described in section 2.13 using gene-specific primers. The PCR 
products were size fractionated by electrophoresis on a 1  agarose gel and 
visualised under UV. The remainder of the colonies of positive clones left on L 
agar plates was used to inoculate 10 mL L broth containing 100 g/mL ampicillin 
and incubated on a shaker overnight at 37 
o
C. Glycerol stocks of each clone were 
prepared as described in section 2.5.3. The identity of each inserted DNA 
sequence was further confirmed by automated sequencing. 
2.17 DNA Sequencing 
Cultures of three positive clones were streaked on L agar plates and sent to Inqaba 
Biotech, South Africa (http://www.inqababiotec.co.za/) for sequencing.  
2.18 Cell culture 
2.18.1 Cell line 
The H9c2 cell line that was used as an in vitro model in this study (Figure 2.6) is a 
sub-clone of the original clonal cell line derived from embryonic BDIX rat heart 
tissue (Kimes and Brandt, 1976). It exhibits many of the properties of skeletal 
muscles (Hescheler et al., 1991). The cell line was kindly donated by the MRC/SU 
centre for molecular and cellular Biology, University of Stellenbosch, South 
Africa. 
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Figure 2.6: H9c2 cells viewed using a Nikon inverted light microscope 
(Magnification: 20x). 
H9c2 cells are multinucleated myotubutes formed by fusion of mononucleated 
myoblasts (Kimes and Brandt, 1976). 
2.18.2 Culturing of cells 
Cells were grown in Dulbecco‟s modified Eagle‟s medium (DMEM) (GIBCO, 
USA) supplemented with 10  foetal bovine serum (FBS), 2 mM glutamine and 
antibiotics (2 % penicillin and streptomycin) under standard cell culture conditions 
(humidified incubator maintained at 37 
o
C and 0.5 % carbon dioxide). Growing 
cells were observed daily under a Nikon inverted light microscope to monitor 
confluency and contamination. 
2.18.3 Trypsinisation of cultured cells  
To maintain morphological and biochemical properties of the cell line, cultures 
were passaged when they reached 80 to 90  confluency and were passaged up to 
20 times. Over-confluency and increased passage numbers have been shown to 
cause loss of differentiation in cardiomyocytes (Hescheler et al., 1991; Kimes and 
Brandt, 1976). Adherent cells were detached from the culture flask by decanting 
culture medium and washing the cells with 5 mL sterile PBS (GIBCO Life 
Technologies, USA). Three mL of pre-warmed sterile 2x trypsin (Invitrogen, 
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USA) was added and the cells placed in the incubator at 37 
o
C until completely 
detatched from the bottom of the flask (usually within 10 minutes). Three mL of 
complete growth media was then added to inactivate the trypsin and the mixture 
transferred into a sterile 15 mL tube using a sterile pipette. Cells were recovered 
by centrifugation at 3 000 x g for 3 minutes at room temperature. After 
centrifugation the supernatant was decanted and the cells re-suspended in 5 mL 
DPBS (Invitrogen Life Sciences, USA) followed by centrifugation at 3 000 x g for 
3 minutes at room temperature. The supernatant was again decanted and the cell 
pellet re-suspended in complete DMEM. Five mL of cell suspension were then 
added into each sterile 25 cm
3
 cell culture flask and placed in an incubator at 37 
o
C.  
2.18.4 Freezing cells 
Frozen stocks of H9c2 cells were made for future propagation of the cell line. 
Confluent cells were washed with sterile PBS and trypsinized as described in 
section 2.18.4 and cells recovered by centrifuging at 300 x g for 3 minutes at room 
temperature. The cell pellet was washed with 5 ml of sterile PBS and again cells 
recovered by centrifugation at 300 x g for 3 minutes at room temperature. The cell 
pellet was then re-suspended in FBS containing 10  DMSO and dispended into 2 
ml aliquots in cryo-vials. Aliquots were immediately placed at -150 
o
C. 
2.18.5 Transfection of cells 
Only actively growing and regularly passaged cells were transfected with high 
quality plasmid DNA prepared by double CsCl/ethidium bromide fractionation. 
Metafectene
TM
 (Biontex, Germany) tranfection reagent was used according to the 
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manufacturer‟s instructions. The following mixtures were prepared in sterile 1.5 
mL tubes: 
Solution A: 1 µg of DNA in 50 µL of serum-free DMEM 
Solution B: 6 µL of metafectene
TM
 transfection reagent in 50 µL of serum-free 
DMEM. 
Both solutions were mixed gently by carefully pipetting up and down several 
times. Solution A was combined with Solution B and mixed gently by slowly 
pipetting up and down several times and incubated at room temperature for 20 
minutes to allow lipid/DNA complexes to form. The transfection mixture was 
added to pre-washed cells in a 6 well plate in a drop-wise manner. 500 µL of 
serum-free media was then added to each well and the lipid/DNA complexes 
distributed evenly by gently swirling the plate. Cells were incubated at 37 
o
C for 4 
hours and constantly monitored for bacterial and/or fungal contamination. After 
incubation 2 mL of complete DMEM were added to each well and cells further 
incubated at 37 
o
C for 48 hours before selection for positively transfected cells. 
Non-transfected controls were included in all transfection experiments to test the 
efficacy of the selection agent. 
2.19 Isolation of total cellular proteins from cell cultures 
Total proteins were extracted from confluent H9C2 cells using RIPA buffer. Cells 
were firstly washed in cold PBS and then 5 mL of cold PBS containing 1 % 
protease inhibitors was added. Cells were gently scrapped off (20-30 strokes) 
using a sterile cell scrapper and recovered by centrifugation at 3 000 x g for 3 
minutes at 4 
o
C. The cell pellet was then resuspended in 300 µL RIPA buffer 
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containing 1 % protease inhibitors and then placed on ice for 15 minutes. This was 
followed by centrifugation at 14 000 x g for 20 minutes at 4 
o
C. The supernatant 
containing proteins was transferred to a fresh 1.5 ml tube and stored at -80 
o
C until 
further use. 
2.20 Sodium dodecylsulphate polyacrylamide gel electrophoresis (SDS-
PAGE) and protein transfer 
Proteins were separated by sodium dodecyl sulphate polYacrylamide gel 
electrophoresis (SDS-PAGE). To make a 12 % gel, 4.0 mL deionised water were 
mixed with 2.5 mL of 1.5 M Tris-HCl (pH 8.8), 3.5 mL of Acrylamide/Bis (37 %), 
0.1 mL of 10 % sodium dodecyl sulphate (SDS) and 0.08 ml of 10 % freshly 
prepared ammonium persulphate (APS). 0.006 ml of TEMED was added to 
polymerise the gel. The mixture was then poured into a gel casting apparatus and 
overlaid with isopropanol. After solidifying the isopropanol was poured out and a 
staking gel prepared by mixing 6.2 mL of water with 2.5 mL of 0.5 M Tris-HCl 
(pH 6.7), 1.3 mL of Acrylamide/Bis (37 %), 0.1 mL of 10 % SDS, 0.08 mL of 10 
% APS and 0.006 mL of TEMED was poured on top of the separating gel and 
allowed to polymerise. One volume of protein sample was then mixed with an 
equal volume of sample loading buffer followed by three cycles of boiling for 5 
minutes and vortexing. Samples were then centrifuged at 14 000 x g for 5 minutes 
and immediately 20 µL of supernatant was loaded onto the pre-run gel and 
electrophoresis carried out at 100 V. After electrophoresis, proteins were 
transferred onto an activated (by immersion into methanol) polyvinylidene 
fluoride membrane by applying 100 V of current in transfer buffer for 1 hour at 4 
o
C. After 1 hour, the transfer apparatus disassembled and the membrane carefully 
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stripped off. To confirm successful transfer of proteins, the membrane was stained 
with Ponceau‟s stain. After confirmation the stain was washed off the membrane 
by using deionised water. 
2.21 Probing the blot with antibodies 
The membrane was washed in TBS for 10 minutes and placed in 5 % blocking 
solution (low-fat powdered milk prepared in TBS Tween- TBST) and placed on a 
shaker for 1 hour at room temperature. A mouse Hsc/Hsp70 polyclonal primary 
antibody (1
o 
Ab) (Assay designs, USA) was diluted at 1:2 500 in 0.5 % blocking 
solution and added onto the membrane which was then placed on a shaker for 1 
hour at room temperature. This was followed by three washes, each for 10 
minutes, with TBST after which the blot was incubated in 1 % blocking solution 
for 10 minutes. A horse raddish peroxidase (HRP)-conjugated goat anti-mouse 
secondary antibody (2
o 
Ab) (Assay designs, USA) was diluted at 1:5 000 in 1 % 
blocking solution and added to the membrane  followed by incubation on a shaker 
for 1 hour at room temperature. The membrane was then washed three times in 
TBST, for 15 minutes each wash.  
2.22 Detection and exposure 
The SuperSignal West Pico (Thermo Fisher Scientific, USA) chemiluminescence 
detection substrate was prepared and added onto the surface of the blot containing 
proteins followed by incubation in a dark place for 5 minutes. After incubation 
excess detection solution was drained off and detection was done using 
autoradiography. The blot was exposed to X-ray film for 20 minutes in a dark 
room. After exposure the film was developed using an x-ray processor. 
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2.23 Isolation of total ribonucleic acid (total RNA) from cells 
Total RNA was isolated from cultured cells using TRIzol reagent (Invitrogen Life 
Sciences, USA) according to the manufacturer‟s instructions. Prior to RNA 
isolation, all pipettes to be used and the work area were thoroughly sanitised with 
75  ethanol diluted with DEPC-treated water. Micro tubes were washed with 
DEPC-treated water and further sterilised by autoclaving. Sterile gloves were worn 
and asceptic techniques practised throughout the procedure to prevent RNase 
contamination.  
2.23.1 Homogenisation 
Cells were lysed directly by adding 1 mL TRIzol
®
 reagent to the 25 cm
3
 culture 
flask and passing the cell lysate through a pipette several times. Insoluble material 
was removed from the homogenate by centrifugation at 10 000 x g for 10 minutes 
at 4 
o
C. The resulting pellet contained extracellular membranes, polysaccharides, 
and high molecular weight DNA, whilst the supernatant contained RNA. The 
cleared homogenate solution was then transferred to a fresh 2 ml tube.  
2.23.2 Phase separation 
The homogenate solution was incubated for 5 minutes at room temperature to 
permit the complete dissociation of nucleoprotein complexes. Chloroform (0.2 mL 
per mL of TRIzol® reagent used in the initial homogenisation step) was then 
added and the solution vigorously shaken by hand for 15 seconds. This was 
incubated at for 3 minutes room temperature and then by centrifugation at 10 000 
x g for 15 minutes at 4 
o
C. After centrifugation, the mixture separated into a lower 
red, phenol-chloroform organic phase, and a colourless upper aqueous phase 
containing RNA.  
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2.23.3  RNA precipitation 
The upper aqueous phase was transferred into a fresh 2 mL tube, taking care not to 
disturb the interphase. RNA was then precipitated by adding 0.5 mL of ice-cold 
propan-2-ol per mL of TRIzol
®
 reagent used in the initial homogenisation step. 
Samples were incubated for 1 hour at -20 
o
C and the RNA recovered by 
centrifugation at 10 000 x g for 10 minutes at 4 
o
C.  
2.23.4 RNA wash 
The supernatant was decanted and the RNA pellet washed once with 75  ethanol 
in DEPC-treated water, adding at least 1 mL of 75  ethanol per mL of TRIzol
®
 
reagent used for the initial homogenisation. Samples were mixed by vortexing 
briefly and then centrifuged at 6 000 x g for 5 minutes at 4 
o
C. 
2.23.5 Re-dissolving the RNA 
After centrifugation, the supernatant was decanted and the RNA was briefly air-
dried at room temperature, taking care not to allow the pellet to dry completely as 
this greatly decreases its solubility. The RNA pellet was then dissolved in DEPC-
treated, RNase-free water and the quality and concentration of the RNA 
determined by measuring OD at 260 nm using a ND 1 000 spectrophotometer 
(NanoDrop technologies, USA). RNA samples were stored at -80 
o
C until 
required. 
2.23.6 Assessing RNA quality 
2.23.6.1 RNA integrity 
RNA quality and concentration were determined using the Agilent 2100 
Bioanalyser (Agilent Technologies, USA). This technology is based on a 
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combination of microfluidics, voltage-induced sizing fractionation in gel-filled 
channels, and laser-induced fluorescence detection (Schroeder et al., 2006). 
Analysis is automated and generates electropherograms and gel-like images 
showing separation of the 18S and 28S rRNA subunits. An RNA sample is 
assigned an RNA integrity number (RIN) on a scale of 1.0 to 10.0 (Figure 2.7). 
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Figure 2.7: An example of electropherograms of different RNA samples with 
varying RIN (adapted from http://openwetware.org). 
A RIN of 10 indicates RNA of highest integrity whilst a RIN of 1 indicates a 
completely degraded RNA sample. 
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2.23.6.2 Agarose gel electrophoresis of RNA 
Total RNA was size fractionated by electrophoresis in a 1.2 % agarose gel 
containing 1.27 % formamide and 0.5 µg/ml ethidium bromide and 
electrophoresed with 1x MOPS. The RNA sample was mixed with formamide 
buffer before loading onto the gel. RNA was visualised with short wave UV light 
on a transilluminator and photographed using the Sony UVP Image Store 5000 
photographic system (Sony, USA). 
2.24 Reverse transcription (RT) 
First strand complementary deoxyribonucleic acid (cDNA) was synthesised from 
tRNA using the ImProm-II
TM
 Reverse Transcription System (Promega, USA).  
2.24.1 Target RNA and oligo(dT) primer combination and denaturation 
Total RNA and components of the ImProm-II reverse transcription (RT) kit were 
thawed on ice. One µg of RNA was then combined with 1 µL oligo(dT) in 
nuclease-free water  to give a final volume of 5 µL (Table 2.6).  
Table 2.6: Experimental reaction mix. 
REACTION COMPONENT VOLUME (µL) 
Nuclease-free water - 
RNA (1 µg/reaction) - 
Oligo (dT) primers (0.5 µM/reaction) 1.0 
FINAL VOLUME 5.0 
 
Tubes were then sealed tightly with parafilm and placed into a heating block 
equilibrated for 5 minutes at 70 
o
C. After incubation the samples were 
immediately place on ice and incubated for at least 5 minutes followed by 
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centrifugation at 10 000 x g for 10 seconds at 4 
o
C in a benchtop microcentrifuge 
to collect the condensate and maintain the original volume. Samples were then 
placed on ice until the reverse transcription (RT) reaction mix was ready. 
2.24.2 Reverse transcription reaction 
The reverse transcription (RT) reaction was prepared by mixing the following 
components of the ImProm-II
TM
 Reverse Transcription System in a sterile 1.5 mL 
tube on ice (Table 2.7). 
Table 2.7: Reverse transcription reaction mix. 
REACTION COMPONENT VOLUME (µL) 
Nuclease-free water 4.5 
ImProm-II
TM
 5x reaction buffer 3.0 
MgCl2 (final concentration 6.25 mM) 5.0 
dNTP mix (final concentration 0.5 mM each dNTP) 1.0 
Recombinant RNasin
®
 Ribonuclease Inhibitor 0.5 
ImProm-II
TM
 Reverse transcriptase 1.0 
FINAL VOLUME 15.0 
 
15 µL aliquots of the RT mix were then added to each reaction tube on ice to give 
a final RT reaction volume of 20 µL. Tubes were sealed off with parafilm and 
placed on a heat block for 5 minutes at 25 
o
C to allow the primers to anneal. After 
incubation tubes were then transferred onto a heat block at 45 
o
C and incubated for 
1 hour after which reverse transcriptase was thermally inactivated by incubation 
for 15 minutes at 70 
o
C. Stock cDNA samples were stored at -20 
o
C.   
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2.25 Real-time quantitative reverse transcription polymerase chain reaction 
Quantitative reverse transcription polymerase chain reaction (qRT-PCR) was 
optimised on the LightCyler
® 
(version 4.1) (Roche, Germany) using gene-specifc 
primers, cDNA and the LightCycler
® 
FastStart DNA Master SYBR Green I kit 
(Roche, Germany) at the Biotechnology Department, University of the Western 
Cape. Annealing temperature, magnesium chloride (MgCl2) concentration, primer 
concentration, template concentration and the cycling programme were optimised 
for the hypoxanthine phosphoribosyltransferase 1 gene (HPRT1), which was used 
as the endogenous reference gene, and each of the target genes (Table 2.8). A 
melting curve analysis was carried out after amplification in order to distinguish 
between specific and non-specific PCR products and primer dimers. 
2.25.1 Primer design for qRT-PCR 
Primers were designed to amplify part (from 120 to 200 bp) of the coding 
sequence of each target gene (http://www.ncbi.nlm.nih.gov/) using the Primer3 
software (http://frodo.wi.mit.edu/primer3/) (Table 2.8). 
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Table 2.8: Forward and reverse primer sequences designed to amplify each of the 16 target genes and the endogenous reference gene HPRT 
1 using qRT-PCR.                                        
Gene Forward primer (5΄-3΄) Reverse primer (5΄-3΄) Expected size (bp) 
HPRT 1 TGACACTGGCAAAACAATGCA GGTCCTTTTCACCAGCAAGCT 185 
Atic TGTCTGTCAGTTCCGATGCT TGTATGAGCCAACACGATCC 148 
Calcyclin-binding protein GCCTTCCTACGACACTGAGG GTCTTCCCTGGCTTGCTTCT 142 
Hsp27 TTGGTGTCCTCTTCCCTGTC GCTCCAGACTGTTCCGACTC 149 
Hsp70i TCATCTCCTGGCTGGACTCT TAATCCACCTCCTCGATGGT 196 
Hsp90 CTGTCTTCCGGCTTCAGTCT CTTCTTCCATGCGTGATGTG 163 
Moesin GCGTGTGCAGAAGCATCTTA CAAATTCATCAATGCGCTGT 167 
Poly(A)-binding protein CTGGCATGCTGTTGGAGAT TGGCACTGTTCACTGCTTTC 153 
RhoE ACTGGAGCAGCCACTTACAT TCTGGTCTGCTAGGCATGTG 170 
Karyopherin α-3 TGCAGCAACATGAAAATGAAG GTTGGCTGTTGGGTCAAAAT 128 
α-β crystallin GACGTGGATCCTCTCACCAT ACTTCTTAGGGGCTGCAGTG 144 
α-spectin GAGGGCAAGCCTTATGTGAC GAGAGAACGGGTGAACTCCA 174 
Clathrin (heavy chain) GAGAGAACGGGTGAACTCCA GGGGCTGACCATAAACAATG 169 
Prolin-4 hydroxylase AGGGCACAGATGTATTCTGG CTTCCGTTGTTCCACAAGGT 146 
Filamin-α AGGCCAGAAGAGCAACTTCA ACTCCCCTTTGTCCTTGAGC 172 
Formin-binding protein TCGGGACAGTGAAAAAGACA TCATCATCCAGTTGCTCCAA 165 
Adrenegic- α-ID TCCCATAAGATTCGCTCTGG GTCAGTCTCTCGGAGGTTGC 176 
 
 
 
 
  
77 
 
All kit reagents were thawed on ice for 15 minutes before use and the LightCyler
® 
FastStart DNA Master SYBR Green I vial was places in an aluminium foil to 
shield the SYBR Green I fluorescence dye from sunlight. LightCyler
® 
capillaries 
were placed in pre-chilled centrifuge adapters, taking care not to touch the surface 
of the capillaries. After thawing, the LightCyler
® 
FastStart DNA Master mix vial 
and the LightCyler
® 
FastStart Enzyme vial were briefly centrifuged and 10µl of 
the enzyme were added to each master mix vial and mixed gently by pipetting up 
and down several times. The qRT-PCR cocktail was then prepared in a 1.5 ml tube 
on ice as shown on Table 2.9. 
Table 2.9: Real-time qRT-PCR cocktail using the LightCycler
® 
FastStart DNA 
Master SYBR Green I kit.  
For multiple reactions, the amount in the “volume” column was multiplied by z, 
where z = the number of reactions to be run plus one additional reaction. 
REACTION COMPONENT VOLUME (µL) 
ddH2O 12.4 
MgCl2 (25 mM stock solution) 1.6 
F-primer (10x) 1.0 
R-primer (10x) 1.0 
10x LightCycler
® 
FastStart DNA Master SYBR Green I 2.0 
cDNA 2.0 
FINAL VOLUME 20.0 
 
The mixture was mixed gently by pipetting up and down several times and 18 µL 
were pipetted into each capillary. 2 µL of water was added into non-template 
control (NTC) capillaries and 2 µL ( 50 ng) of template cDNA was added to 
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reaction capillaries which were then sealed with a supplied stoppers. The 
LightCycler
®
 adapters containing capillaries were centrifuged at 3000 x g for 30 
seconds at room temperature. After centrifugation, the capillaries were transferred 
into the sample carousel of the LightCycler
® 
instrument and amplified according 
to the optimised program. Each reaction was run in duplicate and a NTC was 
included for each target template. The general cycling program is shown on table 
Table 2.10. 
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Table 2.10: General qRT-PCR cycling program. 
Program Step Temperature Time Temperature transition rate Fluorescence acquisition mode 
Pre-incubation  95 oC 10 min 20 oC /sec None 
Amplification Denaturation 95 oC 10 sec 20 oC /sec None 
Amplification Annealing Primer-dependent 10 sec 20 oC /sec None 
 Amplification Extension 72 oC 8 sec 20 oC /sec Single 
Melting curve Denaturation 95 oC 0 20 oC /sec None 
Melting curve Annealing 65 oC 15 sec 20 oC /sec None 
Melting curve Melting 95 oC 0 0.1 oC/sec Continuous 
Cooling Cooling 40 oC 30 sec 20 oC/sec None 
x40  
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2.25.2 Generation of standard curves 
Standard curves were generated for the reference gene and some of the target 
genes by using four serial dilutions of the control cDNA (i.e., NHS H9c2). The 
template concentrations were given arbitrary values of 1 (for the undiluted cDNA), 
0.1 (for the 10-fold dilution), 0.01 (for the 100-fold dilution) and 0.001 (for the 
100-fold dilution). Each cDNA dilution was amplified in duplicate as shown on 
Table 2.10. Threshold cycles (Cts) were determined using „fit-points‟ under the 
„arithmetic‟ function on the LightCycler® software 4.1 (www.roche-applied-
science.com). The software was then used to plot average Ct values against log 
cDNA concentration to generate standard curves.  
2.25.3 Amplification efficiency (E) 
The amplification efficiency (E) of each gene was calculated according to the 
equation below: 
E = 10 
(-1/S) 
            (Pfaffl et al., 2002) 
Where E: amplification efficiency, S; slope of the respective standard curve. 
2.25.4 Relative gene expression 
The expression levels of target genes were calculated relative to an endogenous 
reference gene (HPRT1) using both the ∆Ct and the ∆∆ Ct methods. 
2.25.4.1 The ∆ct method 
Using this method gene expression was calculated and expressed as a normalised 
ratio relative to the expression of HPRT1 in the same sample as shown in the 
equation below: 
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(Pfaffl, 2001; Pfaffl et al., 2002) 
Where R: relative expression, Etarget: amplification efficiency of the target gene, 
Eref: amplification efficiency of the reference gene, ∆Ct, average difference 
between the Cts of the control and experimental samples).  
 
This was the preferred method of calculation as it takes into consideration the 
specific E values of each target gene and reference gene.  
2.25.4.2 The ∆∆ct method 
The ∆∆ct method was used to quantify relative expression levels of genes with 
comparable amplification gradients in the absence of E values. The ∆∆ct method 
differs from the ∆ct method in that it assumes that the E value is constant and 
maximal amongst the various target genes.  
The following steps were taken to normalise and calculate gene expression: 
Step 1: calculating ∆ct for both the target gene and the reference gene   
Ct (treatment) - Ct (control) = ∆ct 
Step 2: normalisation to the endogenous  reference gene 
∆ct (target gene) - ∆ct (reference) = ∆∆ct 
Step 3: calculate fold change in gene expression using the formula: 
R = 2
-∆∆ct
                (Livak and Schmittgen, 2001) 
R =
(Etarget)
ΔCt
target (control – sample)
(Eref)
ΔCt
ref (control – sample)
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2.25.5 Quantification of relative gene expression in H9c2 cells by qRT-PCR 
2.25.5.1 Heat shock assays 
H9c2 cells were heat shocked at 42 
o
C for 1 hour and allowed to recover in fresh 
medium at 37 
o
C for 2 hours. Total RNA was then extracted from both heat 
shocked and non-heat shocked (control) cells as described previously in section 
2.23. First strand cDNA was reverse transcribed from 1 g of total RNA as 
described in section 2.24 and used as a template in qRT-PCR. Relative expression 
of the 16 genes (Error! Reference source not found.) in heat shocked samples 
as calculated using average Ct values as described in section 2.25.4.1.   
2.26 Cytoprotection Assays 
H9c2 cells were seeded in sterile 6-well cell culture plates at a density of 2.0 x 10
5
 
cells/mL and incubated for 24 hours at 37 
o
C. To induce heat shock, seeded 
culture plates were sealed with parafilm and submerged into a pre-heated water 
bath at 42 
o
C for 1 hour. After the heat shock treatment culture media was 
immediately replaced with fresh medium and the cells placed at 37 
o
C and 
allowed to recover for 0, 1, 2, 4 and 6 hours before being treated with 10  
ethanol for 4 hours. A non-heat shocked control was included for comparison in 
each heat shock-induced cytoprotection experiment. Percentage apoptosis was 
then quantified by APOPercentage
TM
 apoptosis assay (Section 2.27). 
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2.27 The APOPercentageTM apoptosis Assay 
Percentage cell death was detected and quantified by measuring fluorescence 
using the APOPercentage
TM
 apoptosis assay (Biocolor, UK). H9c2 cells were 
seeded in 6-well culture plates at a density of 2.0 x 10
5
 cells/ml and placed in a 
humidified incubator for 24 hours at 37 
o
C. The culture media was then removed 
and replaced with media containing 10  ethanol. Non-treated controls were 
included in each treatment to ascertain that healthy cells were used for the assay. 
Cells were then incubated for 4 hours at 37 
o
C. These conditions had been 
established as optimal under our experimental conditions. After incubation, all the 
media from each well, including floating cells, was transferred to corresponding 
15 ml tubes using a sterile transfer pipette for each transfer. All the wells were 
then washed with 1 ml PBS and the wash also transferred into the corresponding 
15 ml tube containing media and floating cells. Adherent cells were trypsinised 
using 2x trypsin (Invitrogen, USA) and also transferred to their corresponding 15 
ml tubes. Cells were recovered by centrifugation at 300 x g for 5 minutes at room 
temperature. The supernatant was decanted and the residual supernatant aspirated, 
taking care not to disturb the cell pellet. The pellet was then gently re-suspended in 
250 L of a 1:320 (~ 20 g/mL) dilution of APOPercentage
TM
 dye diluted with 
complete DMEM. Cells were then incubated for 30 minutes at 37 
o
C and thereafter 
4 ml of PBS were added to each tube and centrifuged at 300 x g for 5 minutes at 
room temperature The supernatant was discarded and the cell pellet re-suspended 
in 300 l of PBS. Cell staining was measured by flow cytometry at 670 nm using 
filter 3 (FL3) on a Becton Dickinson FACScan instrument (BD Biosciences, USA) 
fitted with a 488 nm argon laser. Acquisition was done in log mode and a 
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maximum of 10 000 cells per sample were acquired and analysed using 
CELLQuest PRO software (BD Biosciences, USA). 
2.28 In silico analysis of gene regulation 
An in silico strategy of analysing regulation of gene expression was developed to 
complement SSH data (Figure 2.8). The strategy was devised to take advantage of 
known transcription mechanisms regulating the expression of HS responsive 
genes. Only the 91 genes identified as up-regulated by SSH were considered for 
the in silico analysis which was done using the Genomatix software suite. 
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Figure 2.8: A schematic illustration of the strategy devised for in silico promoter 
analysis. 
The data generated from SSH analysis was analysed in silico using the Genomatix 
software suite (Genomatix, Germany). Promoter sequences were identified using 
Gene2Promoter and common transcription factor binding sites were predicted 
using MatInspector. Conserved promoter modules were identified using 
ModelInspector and used to construct a promoter model which could then be 
applied to a DNA data base to identify co-regulated genes. 
SSH database Promoter Finding Promoter Sequences
Common Promoter 
Framework
Promoter ModelDatabase search
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2.28.1 Identifying promoter sequences  
Gene2Promoter software was used to predict promoter sequences and only 
experimentally verified sequences or sequences which were supported by 
PromoterInspector predictions were considered in the analysis. Based on these 
criteria the number of putative heat shock inducible genes was reduced to 60. 
2.28.2 Screening promoter sequences for the HSE (V$HEAT) 
MatIspector was used to scan the 60 predicted promoter sequences for the 
presence of the HSE. This represents a potential binding site for HSF1 and 
comprise of inverted repeats of the 5΄-nGAAn-3΄ pentanucleotide sequence. The 
Genomatix sequence matrix for the HSE (V$HEAT) is 5΄RGAAnttcnn3΄ with the 
random expectation value of 9.96. 
2.28.3 Screening HSR genes for the presence of common promoter modules 
The assumption that was made here was that the expression of HSR genes is 
regulated by the same set of transcription factors. As such the hypothesis was that 
the promoter sequences of HSR genes share conserved sequence motifs that 
represent binding sites for these factors. Promoter regions of three known Hsp-
genes (Hsp90, Hsp105β and αβ-crystallin) were used as a basis to identify such 
common promoter modules using the ModelInspector software. The identified 
motifs were then used to screen the 60 genes for their presence. The expression of 
genes that contained these modules was further investigated in H9c2 cells 
following heat shock treatment using qRT-PCR. 
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CHAPTER 3.0: RESULTS 
3.1 Establishing heat shock response in H9c2 cells 
 
Figure 3.1: Western immunoblot of Hsc70/Hsp70 in H9c2 cells (a) and a 
polyacrylamide gel that was used as a sample loading control (b). 
The aim of this experiment was to demonstrate the induction of Hsp70 in H9c2 
cells in response to a mild heat shock treatment under experimental conditions. 
Cells were heat stressed as described in section 2.25.5.1. After recovery, cells 
were harvested and total cellular proteins extracted by using RIPA buffer (section 
2.19). Proteins were separated by SDS-PAGE as described in section 2.20. The 
blotted membrane was then probed with a polyclonal Hsc70/Hsp70 antibody. 
NHS- non-heat shocked. 
 
(a)
(b)
42 oC for 1 hour 43 oC for 30 minutesNHS 
Hsc70
Hsp70
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3.2 Characterisation of heat shock induced cytoprotection 
3.3  
Figure 3.2: Histograms showing the shift in the position of the absorbance peak 
and percentage cell distribution as measured by the APOPercentage
TM
 apoptosis 
assay. 
In an effort to optimise the APOPercentage
TM
 apoptosis assay, H9c2 cells were 
treated with 10 % ethanol for various times (section 2.26) and percentage 
apoptosis measured by the APOPercentage
TM
 apoptosis assay on a FACScan 
machine as described in section 2.27. (a) Untreated cells; (b) Cells treated for 2 
hours; (c) Cells treated for 4 hours; (d) Cells treated for 6 hours. Marker M1 
represents the non-apoptotic cell population whilst Marker M2 represents the 
apoptotic cell population. 
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Figure 3.3: The effects of ethanol concentration and time of exposure on H9c2 
cells.  
The aim of this experiment was to establish a concentration of ethanol and time of 
treatment that would induce between 60 to 70 % cell death.  H9c2 ells were 
exposed to varying concentrations of ethanol for 2, 4 and 6 hours. Percentage 
apoptosis was measured by using the APOPercentage
TM
 apoptosis assay. Error 
bars represent mean ± standard error of three independent experiments. Untr cont, 
untreated control.  
0
10
20
30
40
50
60
70
80
90
%
 A
p
o
p
to
si
s
% Ethanol
2 hrs
4 hrs
6 hrs 
 
 
 
 
  
90 
 
 
Figure 3.4: The APOPercentage
TM
 apoptosis assay showing the exposure time-
dependent effect of 10  ethanol on H9c2 cells.  
Error bars represent mean ± standard error of three independent experiments.  
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Figure 3.5: The cytoprotective effect of heat shock treatment against subsequent 
pro-apoptotic effects of ethanol in H9c2 cells.  
The objective of this experiment was to demonstrate that prior exposure of H9c2 
cells to a mild shock confers resistance to subsequent treatment with an apoptosis-
inducing agent (ethanol). Cytoprotection assays were carried out as described in 
section 2.26 and percentage apoptosis measured by using the APOPercentage
TM
 
apoptosis assay (section 2.27). Error bars represent mean ± standard error of three 
independent experiments. NSH contr, non-heat shocked, untreated control; NHS, 
tr, non heat shocked, treated with 10 % ethanol for 4 hours; 0 hr rec, contr, heat 
shocked, not treated with ethanol and processed at 0 hour recovery after heat 
shock; 0 hr rec, tr to 6 hrs rec, tr, heat shocked samples treated with 10 % ethanol 
for 4 hour after 0 to 6 hours recovery from heat shock at 37 
o
C, respectively. 
3.4 In silico analysis of promoter sequences 
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Table 3.1: Functional classification of up- and down-regulated genes identified 
by SSH. 
The table lists 127 genes that were identified as differentially expressed in H9c2 
cells following heat shock (Gill, 2004). 
Functional 
Classification 
Up regulated Genes Down-regulated Genes 
Heat shock 
proteins/ 
Chaperones 
B-Crystallin, Hsp90, Hsp105 , 
Chaperonin subunit 8  
Cyclophilin A 
Cytoskeleton Moesin, Tropomyosin, Filamin, 
Syndecan2, Destrin, RhoE, -spectrin, -
Parvin, Sarcolemmal associated protein 
Thymosin B4, Vimentin, -
Tubulin 
Transcription Transcription termination factor 
interacting protein 5, Transcription factor 
IIA, Histone deacetylase 1 
Amphoterin, STAT-1 
Protein synthesis PAF67, Eif4g2, Eukaryotic elongation 
factor 1, Ribophorin I, Ribosomal L34 
Phosphoprotein P2 and 
Ribosomals L31, L41, S17, 
S8, S27a, S20  
Calcium Calcyclin binding protein, Annexin IV Calgizzarin 
Signal transduction Thrombospondin 1, Syntenin, Evectin 2, 
PAK 2 
Serum/glucocorticoid 
regulated kinase (sgk), 
Integrin linked kinase 
Transport GosR1, Connexin 43, Transportin-SR, 
Mss4 
MUM2 
Others Damage specific DNA binding protein, 
Arsenite association protein, Silica 
induced gene 81, Desmoyokin, Gpi1, 
Aldose reductase like protein, 
Synaptogyrin 2 
Cytochrome oxidase subunit 
1, Gluthathione-S-
transferase alpha, Formin 
Binding Protein, Ubiquitin-
conjugating enzyme, 
Succinyl-CoA synthethase 
B 
EST’s/Clones 6 EST‟s and 9 cDNA clones of unknown 
function 
2 EST‟s and 5 cDNA‟s of 
unknown function 
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Figure 3.6: Graphic output from MatInpector showing the location of V$HEAT 
in the promoters of known Hsps. 
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Table 3.2: Presence of the heat shock response element (V$HEAT) in the 
promoter regions of genes identified by SSH. 
MatInspector was used to screen the promoter sequences for the presence of the 
heat shock response element (V$HEAT) sequence as described in section 2.28.2). 
Shown in this table is the position of the sequence in the promoter, the strand 
orientation, the actual sequence present in the promoter and the core similarity. 
The nucleotides that conform to the inverted repeat sequence are in bold. 
Gene Name Position Strand Sequence Core 
Similarity 
Moesin 90 - 100 + AGAAagttcct 0.975 
 91 - 101 - GGAActttcta 0.950 
Fms interacting protein 525 - 535 - AGAAtgctcct 0.932 
Cytochrome C oxidase 186 - 196 + AGAAcgctctg 0.936 
X-ray radiation resistance protein 35 - 45 + AGAAtaatcga 0.943 
Eukaryotic translation factor 1 80 - 90 + AGAAggatccg 0.930 
 302 - 312 - TGAAtattcat 0.940 
 303 - 313 + TGAAtattcac 0.940 
Matrin 3 398 - 408 - GGAAcgttccc 0.962 
 399 - 409 + GGAAcgttcct 0.962 
Proline-4 hydroxylase 545 - 555 - AGAAtgctcta 0.937 
Syndecan 2 126 - 136 - AGAAaaatcgg 0.935 
B-Crystallin  606 - 616 - GGAAtcttcct 0.938 
 607 - 617 + GGAAgattcca 0.947 
 949 - 959 + AGAAgcttcac 0.951 
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Table 3.2 continued. 
Gene Name Position Strand Sequence Core 
Similarity 
Hsp90 64 - 74 - AGAAtgttccc 0.982 
 65 - 75 + GGAAcattcta 0.956 
 173 - 183 - AGAAaattcga 0.982 
 174 - 184 + CGAAttttctg 0.938 
Hsp105  415 - 425 - AGAActttcca 0.965 
 416 - 426 + GGAAagttctc 0.960 
Calcyclin binding protein 502 - 512 - GGAAccttcgc 0.955 
 503 - 513 + CGAAggttcca 0.944 
Adrenergic receptor 569 - 579 + AGAAggtccgg 0.932 
Spermine oxidase 139 - 149 - AGAAtgctcac 0.931 
Formin Binding Protein 139 - 149 - AGAAtgctcac 0.931 
Annexin IV 148 - 158 - AGAAggatctg 0.935 
-spectrin  148 - 158 - AGAAggatctg 0.935 
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Table 3.3: The presence of EGRF_SP1F_01 and SP1F_CEBP_01 promoter 
modules and their position on the – and + DNA strands of putative HSR genes. 
Gene Name Position Strand Module Model Score 
Moesin 204-173 - SP1F_CEBP_01 80.5 % 
 223-241 + EGRF_SP1F_01 89.3 % 
 269-241 - SP1F_CEBP_01 80.2 % 
 383-399 + EGRF_SP1F_01 89.0 % 
 423-439 + EGRF_SP1F_01 83.0 % 
 493-468 - SP1F_CEBP_01 80.5 % 
 649-674 + SP1F_CEBP_01 84.2 % 
-Spectrin  117-145 + SP1F_CEBP_01 86.1 % 
 194-210 + EGRF_SP1F_01 89.0 % 
ATIC/IMP cyclohydrolase 405-436 + SP1F_CEBP_01 83.7 % 
 425-405 - EGRF_SP1F_01 86.2 % 
 451-467 + EGRF_SP1F_01 85.6 % 
 489-516 + SP1F_CEBP_01 91.8 % 
 505-489 - EGRF_SP1F_01 91.5 % 
Proline-4 hydroxylase 229-208 - SP1F_CEBP_01 83.2 % 
 229-208 - EGRF_SP1F_01 83.2 % 
 502-518 + EGRF_SP1F_01 84.6 % 
Filamin 264-282 + EGRF_SP1F_01 92.2 % 
 311-283 - SP1F_CEBP_01 82.4 % 
 364-346 - EGRF_SP1F_01 86.6 % 
Karyopherin 290-315 + SP1F_CEBP_01 80.3 % 
 354-338 - EGRF_SP1F_01 89.1 % 
 366-350 - EGRF_SP1F_01 83.5 % 
 673-657 - EGRF_SP1F_01 89.0 % 
B-Crystallin  83-101 + EGRF_SP1F_01 98.4 % 
 1010-981 - SP1F_CEBP_01 82.5 % 
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Table 3.3 continued. 
Gene Name Position  Strand Module Module Score 
Hsp90 358-342 - EGRF_SP1F_01 84.6 % 
 394-368 - SP1F_CEBP_01 82.8 % 
 436-452 + EGRF_SP1F_01 83.2 % 
Adrenergic receptor 50-79 + SP1F_CEBP_01 84.6 % 
 599-583 - EGRF_SP1F_01 90.0 % 
 778-808 + SP1F_CEBP_01 83.2 % 
Formin Binding Protein 114-140 + SP1F_CEBP_01 82.4 % 
 121-103 - EGRF_SP1F_01 97.7 % 
 170-139 - SP1F_CEBP_01 83.4 % 
Clathrin 509-485 - SP1F_CEBP_01 81.5 % 
 612-596 - EGRF_SP1F_01 84.3 % 
 674-697 + SP1F_CEBP_01 80.5 % 
Poly A binding Protein 185-201 + EGRF_SP1F_01 91.9 % 
 441-457 + EGRF_SP1F_01 96.1 % 
 457-426 - SP1F_CEBP_01 84.8 % 
 730-710 - EGRF_SP1F_01 83.3 % 
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3.5 Investigating the expression levels of genes containing conserved sequence 
motifs 
 (a)        
 
(b)     
Figure 3.7: Electropherogram summary of an RNA sample extracted from H9c2 
cells (a) and Gel electrophoresis image showing the 18S and 28S subunits of 
rRNA (b).   
RNA was isolated as described in section 2.23 and RNA quality was analysed by 
using electrophoresis and the Agilent 2100 Bioanalyzer as described in section 
2.23.6.  
 
28S
18S
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Figure 3.8: Real-time qRT-PCR amplification curves showing expression levels 
of HPRT1 and Hsp90 in non heat shocked (NHS) and heat shocked (HS) H9c2 
cells.  
The expression levels of HPRT1 (reference gene) and Hsp90 (a known heat shock 
responsive gene) were analysed by using qRT-PCR as deasribed in section 2.25. 
A no template control (NTC) was included during the amplification for each 
target gene. HS, heat shocked; NHS, non-heat shocked; NTC, no template control; 
Ct, threshold cycle; Cp, crossing point; ΔCt, difference in threshold cycles. 
Threshold cycle (Ct)/Crossing 
point (Cp)
(a) (b)
∆Ct
HS samples NHS samples
HS samples
NHS samples
NTCNTC
Amplification curvesAmplification curves
Cycles
Fl
u
o
re
sc
e
n
ce
 (5
3
0
)
Fl
u
o
re
sc
e
n
ce
 (5
3
0
)
Cycles
 
 
 
 
  
100 
 
 
Figure 3.9: Melting curves (a) and melting peaks (b) for Karyopherin α-3, 
Clathrin, Hypoxanthine phosphoribosyltransferase 1 and Filamin. 
A melting curve was automatically generated by using the LightCycler
®
 software 
to plot fluorescence against temperature for each of the four genes. Plotting the 
reduction in fluorescence over time (-dF/dT) against temperature generated 
melting peaks for each PCR product from which Tm could be determined. Kap, 
Karyopherin α-3; Clt, Clathrin; HPRT1, hypoxanthine phosphoribosyltransferase 
1; Fim, Filamin-α. 
Kap
Clt HPRT1 Fim
Tm
(a)
(b)
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Figure 3.10: Amplification curves of standards (a) and the generated standard 
curve for Atic (b).  
A calibrator sample was serially diluted and amplified by qRT-PCR as described 
in section 2.25.2. Mean Ct for each standard was plotted against log concentratiton 
to generate a standard curve for Atic.  
Error: 0.00352
Efficiency: 2.050
(a)
(b)
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Figure 3.11: Amplification curves of standards (a) and the generated standard 
curve for Cacybp (b).  
A calibrator sample was serially diluted and amplified by qRT-PCR as described 
in section 2.25.2. Mean Ct for each standard was plotted against log concentratiton 
to generate a standard curve for Cacybp.  
Error: 0.00495
Efficiency: 2.078
(a)
(b)
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Figure 3.12: Amplification curves of standards (a) and the generated standard 
curve for HPRT1 (b).  
A calibrator sample was serially diluted and amplified by qRT-PCR as described 
in section 2.25.2. Mean Ct for each standard was plotted against log concentratiton 
to generate a standard curve for HPRT1.  
Error: 0.0187
Efficiency: 2.035
(a)
(b)
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Figure 3.13: Amplification curves of standards (a) and the generated standard 
curve for Hsp27 (b).  
A calibrator sample was serially diluted and amplified by qRT-PCR as described 
in section 2.25.2. Mean Ct for each standard was plotted against log concentratiton 
to generate a standard curve for Hsp27.  
Error: 0.149
Efficiency: 2.015
(a)
(b)
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Figure 3.14: Amplification curves of standards (a) and the generated standard 
curve for Pabpc1 (b).  
A calibrator sample was serially diluted and amplified by qRT-PCR as described 
in section 2.25.2. Mean Ct for each standard was plotted against log concentratiton 
to generate a standard curve for Pabpc1.  
Error: 0.00495
Efficiency: 2.078
(a)
(b)
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Figure 3.15: Amplification curves of standards (a) and the generated standard 
curve for RhoE (b).  
A calibrator sample was serially diluted and amplified by qRT-PCR as described 
in section 2.25.2. Mean Ct for each standard was plotted against log concentratiton 
to generate a standard curve for RhoE.  
Error: 0.0110
Efficiency: 2.146
(a)
(b)
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Table 3.4: Amplification efficiencies (E) of six target gene fragments that were 
amplified by qRT-PCR.  
Amplification efficiencies of target gene were determined from their respective 
standard curves as described in section 2.25.3. 
Gene Amplification efficiency (E) 
Atic 2.050 
Pabpc1 2.078 
Cacybp 2.117 
RhoE 2.146 
Hsp27 2.015 
HPRT1 2.135 
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Figure 3.16: Expression levels of known Hsps in H9c2 cells following heat shock 
treatment. 
Gene expression was measured after two hours of recovery from heat shock at 37 
o
C by using qRT-PCR (section 2.25.4). HPRT1 was used as an endogenous 
reference gene. 
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Figure 3.17: Expression levels of various target genes in H9c2 cells following 
heat shock treatment.  
Gene expression was measured after two hours of recovery from heat shock at 37 
o
C by using qRT-PCR (section 2.25.4). HPRT1 was used as an endogenous 
reference gene. 
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3.6 The over-expression of heat shock responsive genes in H9c2 genes  
 
Figure 3.18: PCR amplification of full coding sequences of Atic (1 779 bp) (a), 
Pabpc1 (1 911 bp) (b) and Hsp27 (618 bp) (c) from cDNA. 
Full coding sequences of Atic, Pabpc1 and Hsp27 were amplified from cDNA by 
PCR. PCR products were extracted by gel electrophoresis (section 2.14) and 
cloned into the MCS of pcDNA3.1(+) as described in section 2.15. A negative 
control (no DNA added) was included in each PCR to verify the template-
specificity of the primers. Lane M represents the DNA size marker, lane C 
represents the negative control, lane A represents the PCR products of Atic, lane 
P represents the PCR product of Pabpc1 and lane HS represents the PCR product 
of Hsp27.  
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Figure 3.19: Agarose gel eletrophoresis images of the undigested pcDNA3.1(+) 
vector (5 015 bp) and after digestion with BamHI and NotI restriction enzymes. 
Plasmid DNA was extracted as described in section 2.9.2 and digested by using 
BamHI and NotI (section 2.10). Products of digestion were separated by agarose 
gel electrophoresis (section 2.14.2). Lane M represents the DNA size marker, 
lane U represents undigested pcDNA3.1(+), lane B respresents pcDNA3.1(+) 
digested with BamHI and lane N respresents pcDNA3.1(+) digested with NotI. 
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Figure 3.20: Colony PCR screen of bacterial colonies for clones containing 
Hsp27. 
Bacterial colonies grown on L agar were used as a template in a PCR with gene-
specific primers so as to identify colonies that contained the vector with the Hsp27 
gene insert. Lane M represents the DNA size marker, lane C represents the 
negative control (no template added) and lanes 1 to 5 represent bacterial colonies 
that were screened. 
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Figure 3.21: Graphic illustration of DNA sequence trace.  
After successful cloning of Atic, Pabpc1 and Hsp27, plasmid DNA samples were isolated from host cells and sent for automated 
sequencing
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> gb|M86389.1|RATHSP27A  Rattus norvegicus heat 
shock protein 27 (Hsp27) mRNA, complete cds 
Length=787 
 
GENE ID: 24471 Hspb1 | heat shock protein 1 [Rattus 
norvegicus] 
 
Score = 1116 bits (604),  Expect = 0.0 
Identities = 617/623 (99%), Gaps = 2/623 (0%) 
 Strand=Plus/Plus 
 
(a) 
 
Query  30   CATGACCGAGCGCCGCGTGCCCTTCTCGCTACTGCGGAGCCCCAGCTGGGAGCCGTTCCG  89 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  43   CATGACCGAGCGCCGCGTGCCCTTCTCGCTACTGCGGAGCCCCAGCTGGGAGCCGTTCCG  102 
 
Query  90   GGACTGGTACCCTGCCCACAGCCGCCTCTTCGATCAAGCTTTCGGGGTGCCTCGGTTTCC  149 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  103  GGACTGGTACCCTGCCCACAGCCGCCTCTTCGATCAAGCTTTCGGGGTGCCTCGGTTTCC  162 
 
Query  150  CGATGAGTGGTCTCAGTGGTTCAGCTCCGCTGGTTGGCCCGGCTATGTGCGCCCTCTGTC  209 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||| | 
Sbjct  163  CGATGAGTGGTCTCAGTGGTTCAGCTCCGCTGGTTGGCCCGGCTATGTGCGCCCTCTGCC  222 
 
Query  210  CGCCGCGACCGCCGAGGGCCCCGCAGCAGTGACCCTGGCC-GCGCCCGCCTTCAGCCGGG  268 
            |||||||||||||||||||||||||||||||||||||||| | ||||||||||||||||| 
Sbjct  223  CGCCGCGACCGCCGAGGGCCCCGCAGCAGTGACCCTGGCCAG-GCCCGCCTTCAGCCGGG  281 
 
Query  269  CGCTCAACCGGCAACTCAGCAGCGGTGTCTCAGAGATCCGACAGACGGCCGATCGCTGGC  328 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  282  CGCTCAACCGGCAACTCAGCAGCGGTGTCTCAGAGATCCGACAGACGGCCGATCGCTGGC  341 
 
Query  329  GCGTGTCCCTGGACGTCAACCACTTCGCTCCTGAGGAGCTCACAGTTAAGACCAAGGAAG  388 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  342  GCGTGTCCCTGGACGTCAACCACTTCGCTCCTGAGGAGCTCACAGTTAAGACCAAGGAAG  401 
 
Query  389  GCGTGGTGGAGATCACTGGCAAGCACGAAGAAAGGCAGGATGAACATGGCTACATCTCTC  448 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  402  GCGTGGTGGAGATCACTGGCAAGCACGAAGAAAGGCAGGATGAACATGGCTACATCTCTC  461 
 
Query  449  GATGCTTCACCCGGAAATACACGCTCCCTCCAGGTGTGGACCCCACCTTGGTGTCCTCTT  508 
            | ||||||||||||||||||||||||||||||||||||||||||||| |||||||||||| 
Sbjct  462  GGTGCTTCACCCGGAAATACACGCTCCCTCCAGGTGTGGACCCCACCCTGGTGTCCTCTT  521 
 
Query  509  CCCTGTCCCCTGAGGGCACACTCACGGTGGAGGCTCCGCTGCCCAAAGCAGTCACACAAT  568 
            ||||||||||||||||||||||||| |||||||||||||||||||||||||||||||||| 
Sbjct  522  CCCTGTCCCCTGAGGGCACACTCACCGTGGAGGCTCCGCTGCCCAAAGCAGTCACACAAT  581 
 
Query  569  CAGCGGAGATCACCATTCCGGTCACTTTCGAGGCCCGTGCCCAAATTGGAGGCCCAGAGT  628 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  582  CAGCGGAGATCACCATTCCGGTCACTTTCGAGGCCCGTGCCCAAATTGGAGGCCCAGAGT  641 
 
Query  629  CGGAACAGTCTGGAGCCAAGTAG  651 
            ||||||||||||||||||||||| 
  Sbjct  642  CGGAACAGTCTGGAGCCAAGTAG  664 
(b) 
 
 
Figure 3.22: BLAST search results for the Hsp27 sequence. 
(a) Gene identity and the quality of alignment. 
(b) Sequence alignment of Hsp27 against the non-redundant nucleotide 
database using BLASTn. 
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Figure 3.23: Colony PCR screen of bacterial colonies for clones containing Atic. 
Bacterial colonies grown on L agar were used as a template in a PCR with gene-
specific primers so as to identify colonies that contained the vector with the Hsp27 
insert. Lane M represents the DNA size marker, lane C represents the negative 
control (no template added) and lanes 1 to 5 represent bacterial colonies that were 
screened. 
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Figure 3.24: BLAST search results for the Atic sequence. 
(a) Gene identity and the quality of alignment. 
(b) Sequence alignment of Atic against the non-redundant nucleotide database 
using BLASTn. 
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> ref|NM_031014.2|  Rattus norvegicus 5-aminoimidazole-4-
carboxamide ribonucleotide  
formyltransferase/IMP cyclohydrolase (Atic), mRNA 
 gb|BC072496.1|  Rattus norvegicus 5-aminoimidazole-4-
carboxamide ribonucleotide  
formyltransferase/IMP cyclohydrolase, mRNA (cDNA clone 
MGC:91657  
IMAGE:7096880), complete cds 
Length=2505 
 
 GENE ID: 81643 Atic | 5-aminoimidazole-4-carboxamide 
ribonucleotide 
formyltransferase/IMP cyclohydrolase [Rattus norvegicus] 
(10 or fewer PubMed links) 
 
 Score = 1502 bits (813), Expect = 0.0 
 Identities = 853/874 (97%), Gaps = 12/874 (1%) 
  Strand=Plus/Plus 
 
 
(a) 
 
Query  28   CATGGCTTCCTCCCAGCTTGCCCTGTTCAGTGTGTCTGACAAAACTGGCCTCGTGGAATT  87 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  62   CATGGCTTCCTCCCAGCTTGCCCTGTTCAGTGTGTCTGACAAAACTGGCCTCGTGGAATT  121 
 
Query  88   TGCCAGAAACCTCGCGTCTCTTGGTTTGAGTTTGGTCGCTTCTGGAGGCACGGCAAAAGC  147 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  122  TGCCAGAAACCTCGCGTCTCTTGGTTTGAGTTTGGTCGCTTCTGGAGGCACGGCAAAAGC  181 
 
Query  148  GATCAGGGATGCTGGCCTGGCAGTGAGAGATGTGTCTGAGCTAACTGGGTTCCCTGAAAT  207 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  182  GATCAGGGATGCTGGCCTGGCAGTGAGAGATGTGTCTGAGCTAACTGGGTTCCCTGAAAT  241 
 
Query  208  GTTAGGGGGGCGTGTGAAAACCTTGCATCCTGCAGTCCATGCTGGAATCTTAGCACGCAA  267 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  242  GTTAGGGGGGCGTGTGAAAACCTTGCATCCTGCAGTCCATGCTGGAATCTTAGCACGCAA  301 
 
Query  268  TATTCCAGAAGATGCTGCTGACGTGGCCAGGCTTGATTTCAACCTCATAAGAGTTGTTGT  327 
            |||||||||||||||||||||| ||||||||||||||||||||||||||||||||||||| 
Sbjct  302  TATTCCAGAAGATGCTGCTGACATGGCCAGGCTTGATTTCAACCTCATAAGAGTTGTTGT  361 
 
Query  328  CTGTAACCTGTACCCGTTCGTGAAGACTGTGGCTTCTCCAGATGTAACCGTTGAGGCAGC  387 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  362  CTGTAACCTGTACCCGTTCGTGAAGACTGTGGCTTCTCCAGATGTAACCGTTGAGGCAGC  421 
 
Query  388  TGTTGAGCAAATTGACATTGGTGGCGTGACCTTACTGAGAGCTGCAGCCAAAAACCATGC  447 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  422  TGTTGAGCAAATTGACATTGGTGGCGTGACCTTACTGAGAGCTGCAGCCAAAAACCATGC  481 
 
Query  448  TCGAGTGACAGTTGTGTGTGAGCCAGAGGACTATGGTGCGGTGGCTGCAGAGATGCAGGG  507 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  482  TCGAGTGACAGTTGTGTGTGAGCCAGAGGACTATGGTGCGGTGGCTGCAGAGATGCAGGG  541 
 
Query  508  CTCTGGTAATAAGGACACCTCCCTGGAGACCAGGCGCCACTTGGCATTGAAGGCATTCAC  567 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  542  CTCTGGTAATAAGGACACCTCCCTGGAGACCAGGCGCCACTTGGCATTGAAGGCATTCAC  601 
 
Query  568  GCATACCGCTCAATATGATGAAGCGATTTCGGATTACTTCAGGAGACAGTACAGTAAAGG  627 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  602  GCATACCGCTCAATATGATGAAGCGATTTCGGATTACTTCAGGAGACAGTACAGTAAAGG  661 
 
Query  628  AATTTCTCAGATGCCCTTGAGGTATGGGATGAACCCCCATCAGACTCCTGCCCAGCTGTA  687 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  662  AATTTCTCAGATGCCCTTGAGGTATGGGATGAACCCCCATCAGACTCCTGCCCAGCTGTA  721 
 
(b) 
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Figure 3.25: Colony PCR screen of bacterial colonies for clones containing 
Pabpc1. 
Bacterial colonies grown on L agar were used as a template in a PCR with gene-
specific primers so as to identify colonies that contained the vector with the 
Pabpc1 insert. Lane M represents the DNA size marker, lane C represents the 
negative control (no template added) and lanes 1 to 5 represent bacterial colonies 
that were screened. 
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> gb|BC083176.1|  Rattus norvegicus poly(A) binding 
protein, cytoplasmic 1, mRNA  
(cDNA clone MGC:91496 IMAGE:7097075), complete cds 
Length=2824 
 
GENE ID: 171350 Pabpc1 | poly(A) binding protein, 
cytoplasmic 1 
[Rattus norvegicus] (10 or fewer PubMed links) 
 
Score =  959 bits (519),  Expect = 0.0 
Identities = 525/528 (99%), Gaps = 1/528 (0%) 
 Strand=Plus/Plus 
 
(a) 
 
Query  26   CCGACATGAACCCCAGCGCCCCCAGCTACCCCATGGCCTCTCTGTACGTGGGGGACCTGC  85 
            |||| ||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  439  CCGAGATGAACCCCAGCGCCCCCAGCTACCCCATGGCCTCTCTGTACGTGGGGGACCTGC  498 
 
Query  86   ACCCCGACGTGACCGAGGCGATGCTCTACGAGAAGTTCAGCCCGGCCGGGCCCATCCTCT  145 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  499  ACCCCGACGTGACCGAGGCGATGCTCTACGAGAAGTTCAGCCCGGCCGGGCCCATCCTCT  558 
 
Query  146  CCATCCGGGTCTGCAGGGACATGATCACCCGCCGCTCCTTGGGCTACGCGTACGTGAACT  205 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  559  CCATCCGGGTCTGCAGGGACATGATCACCCGCCGCTCCTTGGGCTACGCGTACGTGAACT  618 
 
Query  206  TCCAGCAGCCGGCGGACGCGGAACGTGCTTTGGACACCATGAATTTTGATGTTATAAAGG  265 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  619  TCCAGCAGCCGGCGGACGCGGAACGTGCTTTGGACACCATGAATTTTGATGTTATAAAGG  678 
 
Query  266  GCAAGCCAGTACGCATCATGTGGTCTCAGCGTGATCCATCACTTCGTAAAAGTGGAGTAG  325 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  679  GCAAGCCAGTACGCATCATGTGGTCTCAGCGTGATCCATCACTTCGTAAAAGTGGAGTAG  738 
 
Query  326  GCAACATATTCATTAAAAATTTGGACAAATCCATTGACAATAAAGCACTGTATGATACGT  385 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  739  GCAACATATTCATTAAAAATTTGGACAAATCCATTGACAATAAAGCACTGTATGATACGT  798 
 
Query  386  TTTCTGCGTTTGGTAACATCCTTTCATGTAAGGTGGTTTGTGATGAAAATGGCTCCAAGG  445 
            |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  799  TTTCTGCGTTTGGTAACATCCTTTCATGTAAGGTGGTTTGTGATGAAAATGGCTCCAAGG  858 
 
Query  446  GCTATGGATTTGTACATTTTGAAACACAGGAAGCAGCTGAAR-AGCTATTGAAAAAATGA  504 
            |||||||||||||||||||||||||||||||||||||||||  ||||||||||||||||| 
Sbjct  859  GCTATGGATTTGTACATTTTGAAACACAGGAAGCAGCTGAAAGAGCTATTGAAAAAATGA  918 
 
Query  505  ATGGAATGCTTCTAAATGATCGTAAAGTGTTTGTTGGTCGATTTAAAT  552 
            |||||||||||||||||||||||||||||||||||||||||||||||| 
Sbjct  919  ATGGAATGCTTCTAAATGATCGTAAAGTGTTTGTTGGTCGATTTAAAT  966 
(b) 
Figure 3.26: BLAST search results for the Pabpc1 sequence. 
(a) Gene identity and the quality of alignment. 
(b) Sequence alignment of Pabpc1 against the non-redundant nucleotide 
database using BLASTn. 
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Figure 3.27: Relative expression of various target genes in transiently transfected 
H9c2 cells. 
Real time quantitative PCR (section 2.25.4) was use to measure relative 
expression of Hsp27, Atic, Pabpc1 and RhoE in H9c2 cells (section 2.25.4) 48 
hours after being transfected with each expression construct. HPRT1 was used as 
an endogenous reference gene. 
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CHAPTER 4.0: DISCUSSION 
The overall objective of this study was to identify novel regulatory elements in the 
promoters of heat shock responsive genes. In order to achieve this objective and 
gain more insight into regulation of heat shock response in mammalian cells, both 
in silico and in vitro analyses were employed. Such an approach was considered 
very effective as it enabled experimental validation of some of the data generated 
by employing in silico tools. 
4.1 Heat shock optimisation and cytoprotection 
The initial phase of experimentation involved optimisation of the heat shock 
system. Rat heart-derived H9c2 myocytes were used as a simplified in vitro model 
of the myocardium and heat shock was used to induce cellular stress. Western blot 
analysis demonstrated that exposing H9c2 cells to 42 
o
C for one hour induced the 
expression of the Hsc70/Hsp70 complex (Figure 3.1). This increase in 
Hsc70/Hsp70 expression was observed after one hour of recovery at 37 
o
C 
following heat shock treatment. The Hsc70/Hsp70 polyclonal antibody that was 
used for Western blotting recognised both the constitutively expressed Hsc70 and 
the inducible Hsp70 isoforms. The observed increase in the Hsc70/Hsp70 protein 
complex abundance in H9c2 cells following heat shock was largely attributed to 
increased expression of Hsp70, which has been shown to be mostly absent under 
non-stress conditions but rapidly synthesised in response to exposure of cells to 
elevated temperatures (Mosser et al., 2000).  
After optimising experimental heat shock conditions, cytotoxicity assays were 
then carried out to investigate the cytoprotective effect of heat pre-conditioning of 
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H9c2 cell cultures against ethanol, a potent apoptosis-inducing agent. The 
APOPercentage
TM
 apoptosis assay was used to detect and quantify apoptotic cells. 
The assay comprises of an anionic halogenated fluorescein dye which is taken up 
by apoptotic cells at the stage of plasma membrane phosphatidylserine (PS) 
externalisation (Martin et al., 1995). Staining with this dye gives apoptotic cells a 
purple-red colour which can be detected by flow cytometric analysis. As shown in 
Figure 3.2 an increase in the apoptotic cell population (marker M2) was observed 
with increasing the concentration of ethanol. Figure 3.3 shows the effect of 
varying both the concentration of ethanol and time of exposure on H9c2 cells. The 
aim of this experiment was to establish a suitable combination of concentration 
and time of exposure that would cause between 60 – 80 % apoptosis. The rational 
was that this percentage range would enable clear differentiation between 
cytoprotected and sensitive H9c2 cells in subsequent assays. A concentration of 10 
% and an exposure time of four hours satisfied this experimental condition (Figure 
3.4) hence were used in subsequent cytoprotection experiments. Additionally, a 
time dependent effect was only observed when using 10 % ethanol (Figure 3.3), 
which suggested improved consistency at this concentration compared to lower 
concentrations.  
The cytoprotective effect of heat shock preconditioning against the pro-apoptotic 
effects of ethanol was demonstrated by subjecting H9c2 cells to heat shock at 42 
o
C for one hour prior to treating then with 10 % ethanol for four hours. As shown 
on Figure 3.5 heat shock pre-conditioned H9c2 cells were significantly (p<0.05) 
protected from ethanol compared to control cells, more so after two hours of 
recovery from HS. The very low percentage cell death recorded for heat shocked 
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but non-ethanol treated cells („0 hrs rec, tr‟) (Figure 3.5) indicated that the heat 
shock treatment itself did not cause any significant cell death. Thus the observed 
cell death after treatment with ethanol could confidently be attributed to the sole 
effects of ethanol.   
Prior mild heat shock treatment (preconditioning) activates HSR genes which 
leads to increased synthesis of stress responsive proteins. This renders cells more 
resistant to a wide variety of subsequent, more severe insults, including apoptosis-
inducing chemical substances through their chaperoning and anti-apoptotic effects 
as previously shown by Concannon et al. (2003), Paul et al. (2002) and Charette et 
al. (2000). However, caution must be taken when extrapolating results from such 
simplified in vitro models to human disease states because factors such as the 
unnatural cell environment, the number of cell passages, the degree of culture 
confluency, and the chemical composition of the media, may influence the 
outcome.  
4.2 In silico analysis of gene regulation 
Cellular decisions concerning processes such as survival, growth and 
differentiation are regulated at transcription level and are often reflected in altered 
levels of mRNA transcripts. Previous SSH data suggested differential expression 
of 127 mRNAs in rat cardiomyocytes exposed to 42 
o
C for one hour followed by 
recovery for two hours at 37 
o
C. Among the 127 genes, 91 were up-regulated 
whilst 36 were down-regulated. Up-regulated genes included known Hsp-genes 
(e.g., αβ-crystallin, Hsp90, Hsp105β), Calcyclin binding protein/Siah-1 
interacting protein (CacyBP/SIP), RhoE, and Damage-specific DNA binding 
protein, whilst down regulated genes included Cyclophilin A, α-tubulin, 
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Calgizzarin and Formin binding protein. Classification of these genes into 
functional groups revealed that they are involved in wide ranging cellular 
processes including transcription, protein synthesis, cytoskeletal organisation, 
calcium metabolism and signal transduction (Table 3.1). However, although SSH 
offers insight into the global gene expression profile, it is prone to significant 
levels of false positives. Thus, it is vital to validate the data generated by applying 
the technique. Accordingly an in silico strategy of analysing gene regulation was 
devised to complement the SSH data. The strategy was based on the hypothesis 
that HSR genes may be co-regulated by the same transcription factors and that 
their promoters share conserved sequence motifs representing binding sites for 
these factors.  
Only up-regulated genes were considered for the analysis because genes that play 
crucial roles in heat shock response and cytoprotection are typically up-regulated 
following cellular perturbation. Additionally, only genes whose promoter 
sequences have been experimentally verified or that were supported by 
PromoterInspector (www.genomatix.de) predictions were considered in the 
analysis. This reduced the initial number of up-regulated genes to 60 (67 %). 
Interrogation of these putative HSR genes using MatInspector 
(www.genomatix.de) revealed that only 17 out of 60 genes (28 %) contained 
sequence motifs that were highly similar to the core sequence of the heat shock 
element (V$HEAT) in their promoter regions. These included genes that had not 
been previously associated with the heat shock response such as Moesin, Proline-4 
hydroxylase, Eukaryotic translation factor-1, Cacybp and Adrenergic receptor 
(Table 3.2). 
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Since only 28 % of the up-regulated genes were shown to contain V$HEAT in 
their promoters it was subsequently hypothesised that additional heat shock 
responsive CAREs that are yet to be characterised are conserved in the promoters 
of HSR genes. In an effort to identify these consensus sequences, the promoter 
regions of Hsp90, Hsp105β and αβ-crystallin were interrogated using 
ModelInspector software (www.genomatix.de). Two modules were identified in 
all three genes, namely EGRF_SP1F_01 and SP1F_CEBP_01. The 
EGRF_SP1F_01 module comprise of two overlapping sites that bind the 
transcription factors early growth factor-1 (EGRF-1) and stimulating protein-1 
(SP-1). On the other hand the SP1F_CEBP_01 module represents binding sites for 
SP-1 and CCAAT box/enhancer binding protein (CEBP) (www.genomatix.de). 
Screening the 60 up-regulated genes for the presence of EGRF_SP1F_01 and 
SP1F_CEBP_01 revealed that 12 genes (20 %) contained both modules in their 
promoter regions (Table 3.3). Among these Moesin, Proline-4 hydroxylase, α-
spectrin, αβ-crystallin, Hsp90, Adrenergic receptor and Formin-binding protein 
had previously been shown to also contain the HSE.  
Previous studies have shown that SP-1 is essential for Hsp70 gene expression 
(Bevilacqua et al., 2000, Wilke et al., 2000, Bevilacqua et al., 1997, Morgan, 
1989). Additionally, artificial promoter constructs containing multiple SP-1 
binding sites have been shown to be highly responsive to exposure to ethanol 
(Wilke et al., 2000). C/EBP has also been shown to bind the human Hsp70 gene 
(Martínez-Balbas et al., 1995).  Thus based on this knowledge and the outcome of 
in silico analyses, it was proposed that SP-1/EGRF and/or SP-1/CEBP may act 
together to regulate the expression of HSR genes. Notably, a more complex 
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promoter module that would include binding sites for additional heat-activated 
transcription factors (e.g., HSF1) could not be identified during this study.  
4.3 Real-time qRT-PCR analyses  
The expression of the 12 putative HSR genes identified by SSH and in silico 
analysis was further investigated in H9c2 cells by using qRT-PCR (Ginzinger, 
2002; Bustin, 2000). However, successful application of the technique is primarily 
dependent on isolation of RNA of the highest quality (Fleige and Pfaffl, 2006). As 
such the quality of the isolated total RNA was ascertained before it could be used 
for downstream applications (Figure 3.7). Only high-quality RNA was used to 
synthesis cDNA for qRT-PCR analysis. 
The expression of target genes was normalised and expressed relative to that of 
HPRT1 (an endogenous reference gene). Normalisation corrects for variation such 
as that arising from variable RNA or cDNA input. Thus careful selection of a 
reference gene is a vital component of qRT-PCR analysis. HPRT1 was shown to 
be a suitable reference gene as its level of expression in H9c2 cells did not vary in 
response to HS treatment (Figure 3.8). SYBR
®
 Green I fluorescent dye was used 
to detect and quantify the accumulating PCR product during qRT-PCR.  This 
provides the simplest and most economic detection chemistry in qRT-PCR assays. 
However, the main disadvantage of using SYBR
®
 Green I is that it binds 
indiscriminately to double-stranded DNA in the reaction mixture, including primer 
dimmers and non-specific PCR products. This results in overestimation of the 
initial template concentration. To avoid this error, amplification specificity was 
verified by melting curve analysis. As shown on Figure 3.9, a single fluorescence 
peak representing one PCR product of Karyopherin (“Kap”), Clathrin (“Clt”), 
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HPRT1 and Filamin-α (“Fim”) was obtained when the reduction in fluorescence 
over time (-dF/dT) was plotted against temperature (
o
C). The plateau of each 
melting peak coincides with the Tm of that specific PCR product, which enables 
confirmation of the identity of the amplified product.  
Accurate quantification of relative gene expression requires that the E value of 
target genes be maximal. Accordingly E values of various genes were determined 
from their individual standard curves that were generated by plotting Cts of 10-
fold serial dilutions of the control cDNA template against log[10] template 
concentration (Figure 3.10 to Figure 3.15). The slope of the resulting standard 
curve is a function of amplification efficiency. E values were found to be maximal 
and comparable to that of the reference gene (Table 3.4). An E value of 2.0 (as 
determined by using the quoted variant of the equation for calculating E) indicates 
that at the log linear phase of amplification the amount of amplicon doubles after 
each PCR cycle. A low E value, which is often a result of using poor quality RNA 
or co-isolation of RT and/or PCR inhibitors, may contribute to a false-negative 
result.    
Hsp27, Hsp70, Hsp90 and αβ-crystallin were significantly up-regulated following 
exposure of H9c2 cells to a mild thermal stress (Figure 3.16). These are well-
characterised HSR genes that were used as positive controls in the HS assay. 
Generally the putative HSR genes (Pabpc1, Atic, Filamin-α, RhoE and Cacybp) 
showed slight (up to two-fold) induction whereas adrenergic-α-ID was down-
regulated following HS treatment (Figure 3.17). It was noted that although 
Moesin, Proline-4 hydroxylase, Formin binding protein and α-spectrin contained 
the heat shock element in their promoters, these genes were only slightly (<1.25 
 
 
 
 
  
128 
 
fold) up-regulated in response to HS under these experimental conditions. 
However, it is possible that these genes may show higher levels of induction at 
time points other than that employed in this study. Conversely, the promoter of 
RhoE, a confirmed heat shock regulated gene (Ongusaha et al., 2006) was shown 
not to contain V$HEAT, EGRF_SP1F_01 and SP1F_CEBP_01 sequences, yet it 
showed the highest (two-fold) level of heat induction among the interrogated 
genes (Figure 3.17). Possibly this could be a case of indirect regulation as RhoE 
has been shown to be a pro-survival gene that is a transcriptional target of p53, 
which is in turn regulated by heat shock (Ongusaha et al., 2006).  
Several changes occur within the cell during heat shock response, including rapid 
changes in transcription and translation, alterations in cellular metabolism, cell 
cycle arrest, and cytoskeletal reorganisation (Cuesta et al. 2000; Liu et al., 1992). 
Genes that were shown to be up-regulated following HS are associated with some 
of these processes.  
The role played by Pabpc1, Atic, RhoE and Cacybp in stress response is not well 
established. Subsequent to in silico and qRT-PCR analyses, full-length coding 
sequences of two genes showing up-regulation following heat shock (Atic and 
Pabpc1) (Figure 3.18) were cloned into a mammalian expression vector (Figure 
3.19) to facilitate further investigation into their potential cytoprotective roles. The 
successful cloning of each of the three sequences was confirmed by both colony 
PCR and automated sequencing (Figure 3.20 to Figure 3.26). Transient expression 
of each gene construct in H9c2 is shown on Figure 3.27. Interestingly no change in 
the quantity of the Pabpc1 transcript was detected in transfected H9c2 cells. This 
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was attributed to the fact that very high levels of Pabpc1 mRNA generally occur 
in mammalian cells (Ma et al., 2009). 
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CONCLUSIONS AND FUTURE DIRECTIONS 
The combination of in silico and in vitro analyses that was employed in this study 
proved to be a very effective approach as it enabled experimental validation of 
some of the data that were generated by in silico analyses. Two conserved 
modules, namely EGRF_SP1F_01 and SP1F_CEBP_01, were identified in the 
promoter sequences of three known Hsps and 12 putative HSR genes.  These 
modules are believed to be involved in the regulation of HSR genes, in addition to 
known regulatory elements such as the HSE. However, there is a need to further 
investigate the role of these modules in regulating heat shock response using 
techniques such as co-immunoprecipitation.  
Quantitative PCR analyses confirmed that the majority of the 12 genes predicted 
as heat shock responsive by in silico analyses were indeed slightly up-regulated in 
H9c2 cells following HS. These included Atic, Cacybp and Pabpc1. The role of 
these genes in regulation of heat shock response is not well known hence the full 
coding sequences of Atic, Pabpc1, and Hsp27 were cloned in a mammalian 
expression vector to facilitate investigation of the potential cytoprotective roles of 
these genes in future. 
Thus the conclusion drawn from this study was that EGRF_SP1F_01 and 
SP1F_CEBP_01 are regulatory elements that are preserved in promoter sequences 
of HSR genes. These modules are potentially involved in regulating the 
expression of genes in response to heat stress in H9c2 cells. These findings could 
significantly contribute towards a better understanding of regulation of cellular 
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defence mechanisms operating in stressed and/or injured cardiomyocytes and 
provide novel therapeutic targets against stress-induced tissue injury. 
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